University of Louisville

ThinkIR: The University of Louisville's Institutional Repository
Electronic Theses and Dissertations
5-2020

Sulforaphane protects against ethanol-induced apoptosis and
teratogenesis through epigenetic modulation of anti-apoptotic
genes.
Yihong Li
University of Louisville

Follow this and additional works at: https://ir.library.louisville.edu/etd
Part of the Other Pharmacy and Pharmaceutical Sciences Commons

Recommended Citation
Li, Yihong, "Sulforaphane protects against ethanol-induced apoptosis and teratogenesis through
epigenetic modulation of anti-apoptotic genes." (2020). Electronic Theses and Dissertations. Paper 3417.
https://doi.org/10.18297/etd/3417

This Doctoral Dissertation is brought to you for free and open access by ThinkIR: The University of Louisville's
Institutional Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized
administrator of ThinkIR: The University of Louisville's Institutional Repository. This title appears here courtesy of
the author, who has retained all other copyrights. For more information, please contact thinkir@louisville.edu.

SULFORAPHANE PROTECTS AGAINST ETHANOL-INDUCED APOPTOSIS
AND TERATOGENESIS THROUGH EPIGENETIC MODULATION OF ANTIAPOPTOTIC GENES
By
Yihong Li
B.S. Qiqihar University, 2011
M.S. Anhui University, 2014

A Dissertation
Submitted to the Faculty of the
School of Medicine of the University of Louisville
In partial Fulfillment of the Requirements
for the Degree of

Doctor of Philosophy in Pharmacology and Toxicology

Department of Pharmacology and Toxicology
University of Louisville
Louisville, KY

May 2020

SULFORAPHANE PROTECTS AGAINST ETHANOL-INDUCED APOPTOSIS
AND TERATOGENESIS THROUGH EPIGENETIC MODULATION OF ANTIAPOPTOTIC GENES
By
Yihong Li
B.S. Qiqihar University, 2011
M.S. Anhui University, 2014

Dissertation Approved on
April 3, 2020
By the following Dissertation Committee

Shao-yu Chen, Ph. D., (Mentor)

Walter H. Watson, Ph.D.

Lu Cai, Ph.D.

John P. Wise Sr, Ph.D.
.
Qunwei Zhang, Ph.D
ii

DEDICATION

This Dissertation is dedicated to my Parents
Jingfan Dong and Chunzhi Liu
And to my husband
Huadong Fan
For their endless love, patience and encouragement
In all my endeavors

iii

ACKNOWLEDGEMENTS
First and foremost, I would like to thank my mentor, Dr. Shao-yu Chen, for
his continuous guidance and support of my Ph.D study and research, for his
motivation, patience and immense knowledge, and his help in improving my
abilities of critical thinking on the research project, as well as improving my writing
skills. I would also like to thank all my committee members, including Dr. Lu Cai,
Dr. Jone Pierce Wise. Sr, Dr. Walter Walson, Dr. Qunwei Zhang, for their scientific
support, insightful comments, as well as great suggestions.
I am also grateful to Dr. David W. Hein and Dr. Lu Cai, for their efforts to build
the Ph.D. program between Wenzhou Medical University and the University of
Louisville, which offers me the opportunity to study here. I would also like to thank
the present and former faculty and staff in our department for your support and
help with my graduate life.
Many thanks to my labmates, past and present. I am grateful to Jie Liu for
her help and lab management, Dr. Fuqiang Yuan for his help with hNCCs
differentiation experiments, Dr. Ting Wu for her help with the animal study, Dr.
Lanhai Lu for his comments on my research, and Dr. Huadong Fan for his
tremendous help with various experiments.

iv

Thanks to Louisville, which is a lucky place for me. I met my husband here
and we have a beautiful baby after two years of marriage. They are the most
precious gift in my graduate journey.
Finally, I would like to thank my friends and family for their support throughout
my years in graduate school. I would like to thank my parents, parents-in-law and
my niece Qiqi for all of their loving support throughout my life. I would like to thank
my husband, Huadong Fan, for always being there when I need him. All your love
and support have been tremendous. Thank you.

v

ABSTRACT
SULFORAPHANE PROTECTS AGAINST ETHANOL-INDUCED APOPTOSIS
AND TERATOGENESIS THROUGH EPIGENETIC MODULATION OF ANTIAPOPTOTIC GENES

Yihong Li
April 3, 2020
Background. Ethanol-induced excessive apoptosis in neural crest cells (NCCs),
a multipotent progenitor cell population, is one of the major mechanisms underlying
the pathogenesis of Fetal Alcohol Spectrum Disorders (FASD). However, the
molecular mechanisms underlying FASD that results from maternal alcohol
exposure during pregnancy are poorly understood. The overall goals of this study
are to examine the mechanisms by which ethanol induces apoptosis and
malformations in vitro and in vivo, and to develop a nutritional-based approach by
using SFN and SFN-rich BSE to prevent FASD through epigenetic modulation.
Results. This study demonstrates that ethanol exposure resulted in a significant
increase in the DNMT activity and the expression of DNMT3a in human neural
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crest cells. SFN can significantly diminish ethanol-induced increases in DNMT
activity and the expression of DNMT3a. We have also found that ethanol-induced
up-regulation of DNMT3a and an increase in DNMT activity resulted in
hypermethylation at the promoters of the selected anti-apoptotic genes and that
SFN can diminish ethanol-induced hypermethylation at the promoters of the antiapoptotic genes by preventing ethanol-induced up-regulation of DNMT3a and
increase in DNMT activity. In addition, the knockdown of DNMT3a or treatment
with SFN significantly diminished ethanol-induced decreases in the mRNA and
protein expression of NAIP and XIAP and prevented ethanol-induced apoptosis in
human neural crest cells. The knockdown of DNMT3a also enhanced the effects
of SFN on the mRNA and protein expression of NAIP and XIAP and the protective
effects of SFN on ethanol-induced apoptosis. This study also shows that ethanol
exposure can increase HDAC activity and the expression of HDAC2 in human
neural crest cells. SFN treatment significantly diminished ethanol-induced increase
in HDAC activity and the up-regulation of HDAC2. We have also found that
ethanol-induced increase in HDAC activity and up-regulation of HDAC2 resulted
in the reduction of H3 acetylation at the promoters of AKT1, BIRC6 and XIAP and
that SFN diminished ethanol-induced reduction of H3 acetylation at the promoters
of anti-apoptotic genes by inhibiting HDAC activity and reducing ethanol-induced
up-regulation of HDAC2. In addition, SFN treatment or knockdown of HDAC2
significantly diminished ethanol-induced decreases in the mRNA and protein
expression of AKT1, BIRC6 and XIAP and prevented ethanol-induced apoptosis
in human neural crest cells. The knockdown of HDAC2 also enhanced the effects
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of SFN on the mRNA and protein expression of AKT1, BIRC6 and XIAP and the
protection against ethanol-induced apoptosis. In addition, our studies have shown
that ethanol exposure can inhibit EMT through the down-regulation of Snail1 by
decreasing H3K4me3 enrichment at the promoter regions of Snail1 and increase
apoptosis in neural crest cells. SFN treatment can reverse the ethanol-induced
reduction of the H3K4me3 enrichment at the promoter regions of Snail1, restore
the expression of Snail1 and EMT in neural crest cells exposed to ethanol and
diminished ethanol-induced apoptosis. These findings demonstrate that the
disruption of EMT contributes to ethanol-induced apoptosis in neural crest cells
and that SFN can prevent ethanol-induced apoptosis by restoring EMT through
epigenetically regulating the expression of EMT-related genes, suggesting that
elucidation of Snail1’s role in EMT and ethanol-induced apoptosis in neural crest
cells may provide critical insight into the pathogenesis of FASD. Moreover, this
study has demonstrated that SFN-rich BSE can attenuate ethanol-induced
teratogenesis through epigenetically up-regulating the anti-apoptotic genes.
Conclusions. The findings from work presented in this dissertation provide critical
insight into the pathogenesis of FASD. In addition, the potency of SFN in
preventing ethanol-induced apoptosis illustrates the potential of a practical and
promising therapeutic strategy for FASD.
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CHAPTER I

INTRODUCTION
Background
FASD and ethanol-induced apoptosis in NCCs
Fetal alcohol spectrum disorder (FASD) is one of the most common birth
defects caused by maternal drinking alcohol during pregnancy. The recent metaanalysis estimated that the worldwide prevalence of FASD is approximately 7.7
per 1000 population1. The World Health Organization (WHO) European region had
the highest prevalence of FASD, which is 19.8 per 1000 population1. In the United
States, the active case ascertainment studies estimated that 1.1 to 4.8% of schoolaged children might have FASD2. FASD is one of the major public health problems
in this country and in the world.
FASD is characterized by craniofacial abnormalities, including narrow
forehead, short palpebral fissures, elongated upper lip, upturned nose and
deficient philtrum. In addition of the craniofacial dysmorphology, the long-term
consequences of prenatal alcohol exposure include mental retardation, growth
retardation, cognitive deficits and social problems. A number of animal models of
prenatal alcohol exposure have been used to elucidate the mechanisms
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underlying the teratogenic effect of alcohol3-7. A number of studies have
demonstrated that the teratogenesis caused by ethanol is, at least in part,
mediated by excessive cell death in selected cell populations8. Among these, the
neural crest cells (NCCs) are one of the most vulnerable cell populations to ethanol
stimuli during the embryo development9. NCCs is a cell population that arises at
the border of the non-neural ectoderm and the neural plate at the end of
gastrulation. This border, also known as neural fold, flanks the neural plate
bilaterally. During neurulation, the neural plate closes and brings together the
neural folds at the dorsal midline. Subsequently, NCCs go through the epithelialto-mesenchymal transition (EMT), allowing them to delaminate from the
neuroepithelium and to migrate ventrally and differentiate into various cell types10.
In the cranial region, the neural crest gives rise to the majority of the skull and facial
skeleton, teeth, cartilage, tendons, smooth muscles, dermis and melanocytes as
well as neurons and glia of the cranial ganglia11-13. Studies by Kotch and Sulik, as
well as Dunty et al. have shown that ethanol exposure during gastrulation and/ or
neurulation resulted in massive cell apoptosis in hindbrain neuroepithelium as well
as other cell populations including NCCs14. The study by Rovasio has also
indicated that ethanol exposure could induce morphological and dynamic changes
in NCCs in vivo and in vitro15. In addition, study also suggested that ethanol may
directly interfere with the earliest neural crest formation by downregulation of the
inducers of neural crest, which subsequently causes apoptosis in the neural crest16.
The previous studies from our group have also demonstrated that ethanol
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significantly increased apoptosis in NCCs17-19, and that ethanol-induced apoptosis
in NCCs contributes significantly to the ethanol-induced malformation.
Epigenetic regulation and FASD
Epigenetics can be defined as heritable changes in gene expression without
alteration in the DNA sequences. The epigenetic modifications generally include
DNA methylation and histone modification, of which histone can be modified by
methylation and acetylation. Both DNA methylation and histone modification can
alter the accessibility of double strands of DNA to the molecular transcriptional
machinery. Epigenetic regulation can be interfered with by ethanol, leading to
aberrant gene expression and subsequently contributing to the abnormal fetal
development20, 21.
Using animal models of FASD, substantial studies have reported that the
epigenetic alternations, including DNA methylation22-24 and histone modification2529

, are involved in the detrimental effects of prenatal alcohol exposure and

contribute to the abnormalities associated with FASD. A study by Garro has shown
that epigenetic modifications may occur after ethanol exposure during embryonic
development through hypermethylation of fetal DNA, which may contribute to
abnormalities in FASD30. Liu et al. found that extensive methylation occurred in
the developmental genes in alcohol-exposed mouse embryos20. Study has also
shown that exposure to alcohol increased the probability of transcriptional silencing
of the Avy gene in early fetal development31. In addition, it was reported that
prenatal alcohol exposure resulted in alterations in DNA methylation in mice and
consequently led to craniofacial and growth defects that are paralleled to FASD in
3

humans. Zhou and colleagues have also demonstrated that DNA methylation in
the developing nervous system were disturbed by alcohol, leading to
hypermethylation and the repression of the genes, particularly in the genes
involved in neural tube development32, 33. Moreover, the enhanced methylation
was found in imprinted genes, which are essential for cell cycle, growth, apoptosis,
cancer and in a significant number of genes essential for olfaction20. These results
indicated that the ethanol-induced alterations in DNA methylation contribute to the
pathogenesis of FASD.
In addition to DNA methylation, histone modifications also play an important
role in ethanol-induced apoptosis and the pathogenesis of FASD. The earliest
study on the effects of ethanol on histone modifications was conducted on liver
cells. This study has demonstrated that H3K4ac was increased in a time and dosedependent manner in liver cells exposed to ethanol34. It was also reported that
acute alcohol exposure in mice resulted in a strong increase in H3K9me2 and
H3K9ac levels at GD7 and reduced H3K27me3 levels at GD17 and that these
histone modifications correlated with the craniofacial development and the CNS
defects. In the offspring of the alcohol-exposed mice, the H3K4me2 and H3K4me3
were reduced significantly while both acetylated H3K9 and H3K9me2 were
increased35. Consistent with acetylated or methylated histone H3 and H4, the
transcriptional activity of enzymes responsible for gene expression were also
changed36. Those epigenetic changes can persist long after the transient ethanol
signal has disappeared, highlighting the particular importance of this phenomenon
for FASD.
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DNA methylation and apoptosis
During embryonic and fetal development, the epigenetic markers (including
DNA methylation and histone modification) are well established, and its status at
some genomic loci is labile and changes in response to environmental exposure,
including diet and alcohol37. DNA methylation occurs on the cytosine residue of
CpG dinucleotides and is performed by DNA methyltransferases (DNMTs) through
the transfer of 5-methylcytosine from the methyl donor S-adenosylmethionine
(SAM) to the CpG. Three DNMTs (DNMT1, DNMT3a, DNMT3b) are required for
the establishment and maintenance of DNA methylation patterns. DNMT1 is
responsible for the maintenance of established patterns of DNA methylation, while
DNMT3a and DNMT3b mediate the establishment of new or de novo DNA
methylation patterns and play essential roles during embryonic development38. In
mammal, DNA methylation is globally distributed in CpG islands throughout the
entire genome, which are areas rich in CpG dinucleotides and typically located
near the promoter region of genes. Alteration of the DNMT level may trigger hypermethylation or hypo-methylation of gene promoters, which could consequently
result in inhibiting or activating gene expression, respectively. Evidence from
literature indicates that the DNA methylation-mediated regulation of gene
expression is involved in apoptosis, which is an important mechanism through
which tumor cells avoid apoptosis39, 40. These changes can occur either in the form
of hypomethylation to reactivate anti-apoptotic genes or hypermethylation to
repress pro-apoptotic genes40. A study by Pompeia et al. showed that aberrant
methylation by DNMT inhibitor zebularine promoted the expression of some pro5

apoptotic genes (BAD, BAK, BIK and BAX), contributing to growth and survival of
multiple myeloma cells41. The other studies indicated that hypermethylation of the
pro-apoptotic gene Fas in T-cell lymphoma or in colon carcinoma cell lines
correlated to a decrease in Fas expression, thus conferring resistance to
apoptosis42-44, whereas DNMT inhibitor 5-aza-2’-deoxycytidine (5-azadC) can
reverse this effect. Similarly, a study that analyzed the methylation status of proapoptotic gene BNIP3 indicated that the methylation level correlated inversely with
gene expression and also with the reduction of apoptosis45. In addition, it has been
shown that the loss of methylation in the inhibitor apoptosis protein (IAP) promoters
might be related to apoptosis resistance39. Strikingly, Survivin, which is normally
expressed during embryonic development, has been found to be hypomethylated
by DNMT inhibitor and highly overexpressed in different cancers including ovarian,
HCC (Hepato cellular carcinoma) and glioma, conferring resistance to apoptosis 39,
46

. A positive correlation between DNMT1 levels and Survivin methylation status

suggested that DNMT1 is required for Survivin regulation 47. These studies
demonstrate that alterations of methylation at the promoters of apoptotic genes
are associated with apoptosis.
Histone acetylation and apoptosis
Histone modification is one of the major epigenetic modifications. Histone
modifications play a crucial role in many cellular processes during embryonic
development, including cell proliferation, cell survival and cellular differentiation48.
In eukaryotic cells, DNA forms a complex structure with proteins called chromatin.
In chromatin, the fundamental repeat unit is the chromosome, consisting of one
6

octamer comprised of four core histone proteins (H2A, H2B, H3, and H4) around
which 147 base pairs of DNA are wrapped 48,

49

. Chromatin modifications also

shape the epigenome and regulate gene expression in both normal and cancer
cells50. Each of the core histones has an N-terminal “tail” that can be subject to
several covalent modifications associated with euchromatic (open) and
heterochromatic (closed) chromatin states. These covalent modifications are
established by “writers”, such as histone lysine methyltransferase (KMTs), histone
acetyltransferases (HATs). These modifications can be removed by “erasers”,
such as histone demethylases (KDMs), histone deacetylases (HDACs)51. HATs
and HDACs are associated with histone acetylation and deacetylation,
respectively. There are 18 HDACs in humans, and they are distributed into 4
classes: Class I HDACs include HDACs 1, 2, 3 and 8, which are located in the
nucleus. Class I HDACs were reported to regulate neurogenesis, proliferation,
differentiation, and embryonic development52-54. Class II HDACs include HDAC 4,
5, 9, and 10 (Class IIa) as well as HDACs 6 and 10 (Class IIb), which are localized
both in the nucleus and the cytoplasm. Class III HDACs comprise SIRTs 1 to 7,
and class IV is formed by HDAC11 only55. Both HATs and HDACs regulate the
dynamic acetylation balance of histone and nonhistone proteins and play an
important role in cell proliferation, apoptosis, differentiation, cancer treatment,
neuroprotection, and anti-inflammatory effects56-58. The histone deacetylase
inhibitor (HDACi) can interfere with the deacetylase function of HDACs, improve
the acetylation level of histone, and regulate gene expression. Histone acetylation
is associated with activation of transcription. Active genes usually carry high levels
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of lysine acetylation on histone H3 (H3ac) and h4 (H4ac). Moreover, histone H3
lysine acetylation at position 9 (H3K9Ac) and 14 (H3K14Ac) is associated with
open chromatin at the gene promoter region and activate gene expression.
Substantial studies have shown that the HDACis are emerging as a prominent
class of therapeutic agents for treatment of a variety of cancers, such as pancreatic,
ovarian, breast, colon, prostate, and thyroid cancer 59-63. Other studies have also
demonstrated that HDACi has important neuroprotective effects in the treatment
of diseases of nervous system64-67. HDACi are known to inhibit apoptosis, increase
cell survival and enhance anti-inflammatory response64, 65, 68, 69. The study by Dr.
Chuang group showed that HDACi Trichostatin A (TSA) can regulate the
expression of apoptosis-related genes Bcl2 and apaf-1 and improve neurological
performance in the rat permanent middle cerebral artery occlusion (pMCAO)
model of stoke65. Valproic acid (VPA), another HDACi, can also attenuate retinal
neuron apoptosis by inhibiting the activation of caspase 3 and the apoptotic
protease activating factor-1 (apaf-1), and the release of cytochrome C68. It has also
been demonstrated that HDACi increased the acetylation of histone H3, activated
the transcription of downstream genes Akt, Erk, CREB and HSP70, and thus
upregulated the levels of anti-apoptotic proteins Bcl-2 and Bcl-xL, and eventually
led to the downregulation of caspase-365, 70. In addition, a study from Dr. Zhang
shown that VPA protects against neuronal apoptosis by activation of BNDF-TrkB
signaling at the transcriptional levels and that VPA treatment resulted in the
hyperacetylation of histone H3K14, attenuated histone H3K9 hypermethylation in
the BNDF promoter, and promoted transcriptional activity71. A study from this
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group has also demonstrated that VPA upregulated the expression of the antiapoptotic gene Hsp70 by enhancing the acetylation of histone H3 at Hsp70
promoter68. Our recent study has shown sulforaphane (SFN), a well-known HDACi,
restored the expression of the anti-apoptotic gene Bcl-2 and attenuated ethanolinduced apoptosis by enhancing histone H3 acetylation at the Bcl-2 promoter in
NCCs18.
Histone methylation and apoptosis
The other dominant histone modification is the methylation of lysine and
arginine. The regulation of gene expression by histone methylation is correlated
with specific histone methylation of lysine and arginine amino acids of histone Nterminal tails. Histone methylation is well characterized at lysine residues 4, 9, 27,
and 36 of histone H3 and at lysine 20 of histone H4. The effects of histone
modifications on gene expression depend on the position of lysine residues that
are methylated. For example, active genes are marked at their transcript start site
(TSS) by H3K4me3, which facilitates transcriptional initiation50. Moreover, high
levels of lysine trimethylation of H3 lysine 79 (H3K79me3) and trimethylation of H3
lysine 36 (H3K36me3) at the promoter regions of genes also promotes gene
expression72. On the other hand, the histone H3 lysine 27 trimethylation
(H3K27me3) and H3K9 methylation (H3K9me2 and H3K9me3) are linked to the
repression of genes50,

72

. These histone methylations were established by the

writer KMTs and can be removed by the eraser KDMs. Both methylation and
demethylation

of

histones

at

specific

lysine

residues

are

important

posttranslational chromatin-associated modifications73. These modifications are
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known to regulate nuclear function, including transcriptional regulation and
epigenetic inheritance. Removal of repressive modifications (e.g. H3K27me3)
helps to create transcriptional permissive chromatin while removing the permissive
modifications (e.g., H3K4me3) contributes to the formation of repressive chromatin,
suppressing gene expression72. Specifically, trimethylation at H3K4 (H3K4me3)
plays a role in embryonic genome activation 74. Dysfunction of H3K4me3 by a
defect of KMTs results in the down-regulation of STAT3/BIRC5, which is
responsible for the extremely high apoptotic rates of blastocysts 75. In both mice
and human stem cells, most of the H3K4me3-regulated genes are key factors in
basic biological activities and in the maintenance of stem cell pluripotency76, 77.
H3K4me3 markers can be removed by H3K4 histone demethylase KDM5A, which
functions as a repressor by removing di- and tri-methyl groups. Loss of KDM5A
has been shown to regulate cell proliferation, apoptosis and tumorigenesis in cell
culture and in vivo models78, 79. It has been shown that KDM5A positively regulated
metastasis-related genes, including TNC, and that therapeutically targeting
KDM5A inhibited tumor progression78. A study has also shown that KDM5A
knockout mice displayed a mild hematopoietic phenotype , which is correlated with
depression of cytokine genes80. However, unlike histone acetylation, the role of
KDMs in epigenetic regulation of apoptosis during embryonic development has not
been studied so far.
Epigenetic

cross-talk

between

modifications
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DNA methylation

and

histone

Numerous associations exist between DNA methylation and histone
modification. It has been established that DNA methylation at CpG island promoter
can affect methylcytosine-binding proteins (MBD1, MBD2, MBD4 and MeCP1,
MeCP2) to mediate transcriptional repression during gene silencing and
heterochromatin formation81,

82

. The MBD/MeCP1/2 proteins, in turn, recruit

corepressor complexes containing HDACs 1 and 281. The growing evidence
demonstrated that HDACs 1 and 2 are linked to the initiation and/ or maintenance
of repression for DNA hypermethylated genes and that the simultaneous targeting
of both DNA methylation and histone deacetylation leads to synergistic effects to
inactive gene expression. In addition, the links between DNA methylation and
histone methylation have also been demonstrated. Methylation of the histone H3
lysine 9 residue serves to recruit the chromatin silencer HP1 and, in this way, leads
to s gene repression83. The KMT has also been shown to interact with DNMT3a84
and MBD185. Studies have also shown that KDM1A is commonly found in
association with the CoREST transcriptional repressor complex, where it interacts
with HDACs1 and 286, 87. HDAC inhibitor TSA induces hyperacetylation of histones
and the level of H3K4me3, the substrate of KDM5A in the Trichomonas vaginalis88.
Conversely, siRNA-mediated inhibition of KDM1A increases the abundance of
H3K4ac, the substrate of HDAC89. These studies indicated that KDMs and HDACs
were collaborated in establishing transcriptionally repressive chromatin and
suggested that combined treatment targeting both KDM and HDAC may restore
the silenced genes. In fact, studies by Huang et al. and Singh et al. have shown
synergistic responses in cell proliferation in response to combined treatment with
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HDAC and KDM inhibitors89, 90. These studies suggest that combination therapy
using the inhibitors of DNMT, HDAC, and KDM might be a rational approach for
the prevention of FASD.
Epithelial-mesenchymal transition (EMT) and neural crest cells
migration
NCC is a multipotent and migratory progenitor cell population that originates
between the neural plate and non-neural ectoderm10. After induction at the border
of the neural plate, NCCs leave their original location through a delamination
process and migrate ventrally to differentiate into a diversity of neural and nonneural cell types, including neuron, glia, craniofacial cartilage, bone and connect
tissue91-94. EMT process is tightly correlated with the NCCs migration, which plays
a pivotal role in craniofacial development. EMT is a process that orchestrated a
change from an epithelial to mesenchyme phenotype, a process which also related
to cell invasion and apoptotic resistance95, 96. EMT is essential for both normal
development and cancer invasion and metastasis97-99. During embryonic
development, NCCs undergo an EMT and then dissociate from the neural folds
and differentiate to a diversity of cell types10, 91, 93. EMT also plays a vital role in
promoting tumor proliferation, invasion, and metastasis, exerting an anti-apoptotic
effect100,

101

. Studies have also shown that EMT conferred resistance to UV-

induced apoptosis in three murine mammary epithelial cell lines102. Park et al. have
also shown that α-mangostin can inhibit EMT and induce apoptosis in an
osteosarcoma cell line103. However, the role of EMT in ethanol-induced apoptosis
in NCCs and the pathogenesis of FASD remains to be defined.
12

One of the well-known transcriptional factors that regulate EMT is Snail1104106

. Snail1 promotes EMT primarily through the directly repressing E-cadherin, an

EMT suppressing factor104, 107. Many studies have reported that various HDAC
inhibitors promote EMT in prostate cancer, head and neck squamous cell
carcinoma, and colon carcinoma108-110. A study has also shown that VPA, an
HDAC inhibitor, induced EMT process via the up-regulation of Snail1108. The
expression of Snail1 can be regulated by many mechanisms, including epigenetic
regulation. A study by Dong Li et al. demonstrated that the H3K4me3 enrichment
increased in the vicinity of the Snail1 transcriptional start site (TSS) in the process
of TGF-β-induced EMT in prostate cancer cells111.
Sulforaphane is an inhibitor for both DNMTs and HDACs
Sulforaphane (SFN) is a vegetable-derived isothiocyanate that is abundant
in cruciferous vegetables such as broccoli. Numerous studies have shown that
SFN exhibits anti-cancer effects and prevents diabetic complications in
experimental models112-114. Studies on the mechanisms underlying the anticancer
activities of SFN indicate that its effects on the tumor cell cycle, apoptosis, and
angiogenesis are mediated by the modulation of the related signaling pathways
and genes115. Our previous studies have shown that SFN exerts an anti-apoptotic
effect through upregulating antioxidant gene Nrf-2 in NCCs17. More recently, SFN
is drawing great attention because of its ability to inhibit HDACs and DNMTs, two
key enzymes involved in histone deacetylation and DNA methylation, respectively,
to cause epigenetic modification of genes in various types of cells, including the
genes involved in EMT in cancer cells115-117. SFN was found to inhibit the LPS13

induced HDAC6, HDAC10 and DNMT3a gene expression, conferring resistance
to LPS-induced apoptosis in porcine monocyte-derived dendritic cells118. Our
recent studies have also shown that SFN can prevent ethanol-induced apoptosis
in NCCs by reversing ethanol-induced reduction of histone acetylation at the
promoter of the anti-apoptotic gene, Bcl218.
Broccoli sprout extract (BSE)
Recently, broccoli sprout extract (BSE) has gained a lot of attention
because it can specifically deliver a reproducible and standardized dose of
glucoraphanin, a precursor of SFN. The majority of SFN is formed when
glucoraphanin is hydrolyzed by the plant enzyme, myrosinase, upon plant tissue
damage (e.g., chopping, chewing)119. As a precursor of SFN, glucoraphanin is
available in commonly consumed cruciferous vegetables. BSE is considered to
have a low toxicity, and its administration in humans is well tolerated 120-122. Studies
have shown that dietary consumption of cruciferous vegetables, like BSE, which
contains SFN, may reduce the risk of several types of cancers, including prostate,
breast, lung and colorectal cancer119, 123, 124. One of the mechanisms through which
BSE acts as a cancer chemopreventive agent is its ability to inhibit HDAC activity.
It has been reported that consumption of BSE inhibited HDAC activity in peripheral
blood mononuclear cells, accompanied by the induction of acetylation of histone
H3 and H4 in human subjects125. Moreover, the study by Dr. Hashimoto et al. has
shown that dietary intake of SFN-rich BSE was capable of preventing PCP-induced
cognitive deficits and oxidative stress in mice126. Furthermore, SFN-riched BSE
significantly improved social interaction, abnormal behavior, and verbal
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communication in young men with autism spectrum disorders120. Together, these
results suggest that SFN-rich BSE could have potential therapeutic effects in
patients with neurodevelopment problems. Thus, in the present study, I will
investigate whether maternal dietary BSE can confer in vivo protection against
ethanol-induced teratogenesis.
Statement of goal
FASD is a major development defect caused by maternal drinking alcohol
during pregnancy. Growing evidence has shown that ethanol-induced excessive
cell death in the specific cell population is one of the major mechanisms underlying
the pathogenesis of FASD. However, there is a fundamental gap in understanding
how ethanol leads to apoptotic cell death in vitro and in vivo. SFN is a chemical
that is abundant in cruciferous vegetables, including broccoli, SFN is known to
regulate gene expression through an epigenetic mechanism. The goal of this study
is to elucidate the epigenetic mechanisms by which SFN epigenetically regulates
the anti-apoptotic gene expression and prevents ethanol-induced apoptosis and
teratogenesis, as well as to develop new therapeutic approaches for the prevention
of FASD.
Specific aims
Aim1: To identify the anti-apoptotic genes that are epigenetically
silenced by ethanol and de-repressed by SFN in ethanol-induced
hNCCs.
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The objective of this aim is to identify the anti-apoptotic genes that are
epigenetically regulated by SFN and ethanol through DNA methylation or histone
modification. The sub-aims are 1) to identify the anti-apoptotic genes that are
repressed by ethanol and de-repressed by SFN in hNCCs; 2) to identify the antiapoptotic genes that are hypermethylated by ethanol and de-methylated by SFN
in hNCCs; and 3) to identify the anti-apoptotic genes with promoter-associated
histone modifications induced by ethanol and SFN in hNCCs.
Aim2: To further explore the mechanism by which SFN epigenetically
modulates the anti-apoptotic genes and apoptosis.
I expected to identify a group of anti-apoptotic genes that are epigenetically
regulated by ethanol and SFN from Aim 1. The objective of this aim is to further
explore the mechanism by which SFN epigenetically modulates the anti-apoptotic
genes and apoptosis. The three sub-aims in this aim are 1) to determine the effects
of ethanol and SFN on specific DNMT/HDAC/KDM in hNCCs; 2) to analyze the
changes of DNA methylation or histone modification at the promoter of antiapoptotic genes and the expression of selected anti-apoptotic genes in hNCCs
treated with ethanol or/and SFN; and 3) to determine whether SFN prevents
hNCCs from ethanol-induced apoptosis by targeting specific DNMT/HDAC/KDM.
Aim 3: To explore the novel therapeutic approach for the intervention
of

ethanol-induced

teratogenesis

through

administration of SFN-rich broccoli sprout.
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maternal

dietary

Alcohol-induced apoptosis plays an important role in the pathogenesis of
FASD. Therefore, a strategy for the prevention of ethanol-induced apoptosis
through epigenetic modification of the anti-apoptotic genes can be very promising.
The sub-aims in this aim are 1) to determine whether maternal dietary BSE can
epigenetically restore the anti-apoptotic genes in ethanol exposed mouse embryos;
2) to determine whether maternal dietary BSE can prevent ethanol-induced
apoptosis in mouse embryos; and 3) to determine whether dietary consumption of
BSE can confer in vivo protection against ethanol-induced teratogenesis.
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CHAPTER II

EXPERIMENTAL PROCEDURES
Cell culture and treatment
Mouse neural crest cells
Mouse neural crest cells (JoMa 1.3 cells) were cultured on culture dishes
coated with 10 µg/mL fibronectin. NCCs were pretreated with or without 1 µM SFN
(LST Laboratories, St. Paul, MN) for 24 hours, followed by concurrent exposure to
1 µM SFN and 50 or 100 mM ethanol for an additional 24 hours. The stable ethanol
levels were maintained by placing the cell culture dishes or plates in a plastic
desiccator containing ethanol in distilled water.
Human neural crest cells
Human neural crest cells were differentiated from human embryonic stem
cells (hESCs), which were purchased from WiCell® (Madison, WI, USA). hESCs
were cultured in mTsSRTM1 (StemCell Technologies, Inc., Vancouver, Canada) on
hESC-qualified MatrigelTM (BD Biosciences, San Jose, CA) coated plates. The
differentiation procedures are as follows:
1) The hESCs were first adapted to Accutase® solution and dissociated into
single-cell before they were differentiated to neural crest cells. Specifically, the
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hESCs maintenance medium mTsSRTM1 were aspirated, and Accutase® cell
dissociation reagent was added and incubated for 5-10 minutes at room
temperature (RT). The colonies were gently collected once the colonies began to
conform to round shape and to detach from the plate, and centrifuged the cells at
room temperature for 4 min at 200 g. The cells were maintained at 37˚C in a 5%
CO2 incubator and changed the medium with mTsSRTM every day.
2) When hESCs plates have reached 75-85% confluence, they are ready to
be passaged and differentiated into hNCCs. Aspirated hESCs maintenance
medium from culture dish and add Accutase® to detach the cells. Collected the
cells in a 15 mL tube and centrifuged for 4 min at 200 g at room temperature.
Aspirated the supernatant and resuspend the cells in a hNCCs differentiation
medium (DMEM/F-12 Medium, 14.3 M L-Glutamine+β-mercaptoethanol, MEM
Non-Essential Amino Acid, 10 µg/mL Fgf2, 10 µg/mL Heregulin β-1, 200 µg/mL
Long® R3-IGF1, 10 mM CHIR 99021, 10 mM SB421542 and Penicillin and
streptomycin). Upon reaching proper confluence (75%-85%), typically every 3-4
days, the differentiating cells should be passed using Accutase® and then
maintained in hNCCs differentiation medium. The hNCCs were validated by
immunocytochemistry using the NCC marker HNK1 antibody.
Animals and treatments
Mice maintenance, time mating and BSE treatment
C57BL/6 mice were housed in a pathogen-free barrier facility accredited by
the Association for Assessment and Accreditation of Laboratory Animal Care, and
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all procedures used for this study were approved by the University of Louisville’s
Institutional Animal Care and Use Committee.
The female mice were acclimated to a modified liquid diet (Bioserve Inc.)
containing ethanol with 5% sucrose to increase palatability. As described
previously (Parnell et al., 2016), the mice were given a liquid diet containing 2.4%
(wt/vol) ethanol for 2 days, then the concentration of ethanol in the diet was
increased to 4.8% for 14 days. After this acclimation period, the mice were taken
off the liquid diet for an abstinence period for 4 days, during which they were
maintained with the standard chow and water. The mice were then bred by placing
1 or 2 females, with 1 male for a 2 hours period during the beginning of the dark
cycle. The female mice were then examined for a copulation plug. The beginning
of the breeding period in which a copulation plug was found was designated as the
gestational day (GD) 0. SFN-rice broccoli sprout extract (BSE) was provided by Dr.
Jeb Fahey in the Cullman Chemoprotection Center at The Johns Hopkins
University. SFN content in this standardized, myrosinase-treated BSE is around
216 µmol SFN/g powder. The amount of broccoli sprout extract to be incorporated
into the liquid diet was calculated on the basis of the food intake and body weights
of the animals, to give the SFN dosage of 75 mg/kg body weight/day. On GD7 and
GD 8, the mice were assigned to 5 groups and placed back on the liquid diet
containing: 4.8% ethanol (EtOH group), 4.8% ethanol plus BSE (EtOH+BSE
group), BSE alone (BSE group), pair-fed control liquid diet (Pair-fed control group),
and normal liquid diet (control group). Isocaloric amount of maltodextrin was added
to BSE and control groups to control for the calories derived from the ethanol. A
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pair-fed control group was also included in this study to control for effects of the
decreased diet intake observed in the EtOH group. This group of female mice was
given volumes of the control liquid diet that were matched, based on milliliter diet
per gram body weight, to those of the ethanol-exposed mice. During the ethanol
exposure period, body weight and diet consumption were recorded every day.
Pregnant mice were killed on GD 9.0, and embryos were collected for biochemical
studies and the examination of apoptosis and dysmorphology. The other pregnant
mice were returned to lab chow and water until GD 14 for the examination of the
incidence and severity of ocular abnormalities.
Fish maintenance, mating and treatment
Zebrafish were purchased from Zebrafish International Resource Center
(ZIRC; Eugene, OR) and raised and cared for by using the standard protocol127.
All procedures used in this study were approved by the University of Louisville’s
Institutional Animal Care and Use Committee.
Zebrafish were bred and maintained under standard conditions at 28.5˚C in
a zebrafish housing system (Aquaneering; San Diego, CA). The setup was
equilibrated with fish water (75 g NaHCO3, 18 g sea salt, 8.4 g CaSO4 per 1000
mL). Fish embryos were obtained by placing males and females in a setup box
containing a plastic partition plate. The eggs were spawned 2 hours after removing
the partition. Viable embryos were collected and rinsed with fish water. Then the
embryos were treated with 1% ethanol with or without 1 µM SFN during 3 – 24
hours post-fertilization (hpf). For the KDM5A knockdown study in zebrafish
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embryos, ~10 nL morpholino KDM5A was microinjected into the one-cell stage
embryos.
C. Molecular analyses
Nuclear extraction
Nuclear extracts were isolated using the EpiQuik Nuclear Extraction Kit
(Epigentek, Brooklyn, NY), following the manufacturer’s protocol. Briefly, treated
cells were collected and then washed with PBS, resuspended the cells with diluted
NE1 (1: 10 with distilled water) and incubated on ice for 10 min, then centrifuged
the preparation for 1 min at 12, 000 rpm, and discarded the supernatant, followed
by adding 2 volumes of NE2 to the nuclear pellets. Incubated the extract on ice for
15 min, and then sonicated for 3 x 10 seconds by using a Qsonica Q125 sonicator
(QSonica, Newtown, CT) to increase the nuclear protein extraction. Centrifuged
the suspension for 10 min at the maximum speed at 4˚C and transferred the
supernatant into a new tube. The protein concentration was measured by BSA
Assay Reagent (Pierce, Thermo Scientific).
Quantitative real-time PCR
For quantitative real-time PCR, total RNA was isolated from the control and
treated NCCs using a QIAGEN RNeasy mini kit (QIAGEN, Valencia, CA) according
to the manufacturer’s instruction. Total RNA was reverse transcribed using a
QuantiTect Reverse Transcriptional Kit (QIAGEN, Valencia, CA) following the
manufacturer’s instruction. Quantitative RT-PCR was performed on a Rotor-Gene
6000 Real-time PCR system (Corbett LifeScience, Mannheim, Germany). The
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following primer sets were used for this analysis: Snail1 (Mus musculus) forward:
5’-GCCCTGCATCTGTAAGGTGT-3’, reverse: 3’-CCGGGCATTGACCTCATTCT5’; E-cadherin (Mus musculus) forward: 5’-CATCGCCTACACCATCGTCA-3’,
reverse: 3’-CCGGGCATTGACCTCATTCT-5’; β-Actin (Mus musculus) forward: 5’CCATCCTGCGTCTGGACCTG-3’, reverse: 3’-GTAACAGTCCGCCTAGAAGC-5’.
KDM5A (Mus musculus) forward: 5’-AAGTTGCCTGTACGGTTGCC-3’, reverse:
3’-GGAAACTAGGTAAGTGTCCCTGT-5’. Bcl2 (Mus musculus) forward: 5’TCTTTGAGTTCGGTGGGGTC -3’, reverse: 3’- AGTTCCACAAAGGCATCCCAG5’. AKT1 (Mus musculus) forward: 5’- AAGGACCCTACACAGAGGCT-3’, reverse:
3’- TAGGAGAACTTGATCAGGCGG-5’. BIRC5 (Mus musculus) forward: 5’CACCTTCAAGAACTGGCCCT-3’, reverse: 3’- ATCGGGTTGTCATCGGGTTC-5’.
BIRC6 (Mus musculus) forward: 5’- CTGTGAGTTCCTTCGGGGTT-3’, reverse: 3’CTACCTGGGCTGCTGAACTC

-5’.

NAIP

(Mus

musculus)

forward:

5’-

TTCCCCTTACAGCCACCTAAA-3’, reverse: 3’- AGAGGCCTTACTCAGCTCCA5’. MCL1 (Mus musculus) forward: 5’- TGCTCCGGAAACTGGACATTA-3’, reverse:
3’- GTGTTTGGCCACAAAGGCAC-5’. XIAP (Mus musculus) forward: 5’CTGGCCGGACTATGCTCATT-3’, reverse: 3’- CACGATCACAGGGTTCCCAA-5’.
IGF1R (Mus musculus) forward: 5’- TCCGCAACGACTATCAGCAG-3’, reverse:
3’-

GAAGAGTTTCCAGCCACGGA-5’.

Snail1(Danio

rerio)

forward:

5’-

CAGCTTGCTACCTTCCCTTCA-3’, reverse: 3’- GAACGGACGCTCACCTGTAT5’. E-cadherin (Danio rerio) forward: 5’-CAAGGTGGTCCTGAGAGTTGC-3’,
reverse:
forward:

3’-GAGCAGAAGAAGAGCAAGCAATAG-5’.
5’-

KDM5A

ATGATGGAGGGAGACCTGCT-3’,
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(Danio

reverse:

rerio)
3’-

GGGCCCATCTTCAGCTTCTT-5’.

AKT1

(Homo

sapiens)

forward:

5’-

CAGGATGTGGACCAACGTGA-3’, reverse: 3’-AAGGTGCGTTCGATGACAGT-5’.
BCl2 (Homo sapiens) forward:5’- TGGCCTTCTTTGAGTTCGGT-3’, reverse: 3’ACTTGTGGCCCAGATAGGCA-5’.

BIRC5

(Homo

sapiens)

forward:

5’-

AGGACCACCGCATCTCTACA-3’, reverse: 3’- TTTCCTTTGCATGGGGTCGT-5’.
BIRC6 (Homo sapiens) forward: 5’- GGCTAACACCAATGGAGGCT-3’, reverse:3’GGAACTCATTGCATCATCCCT-5’.

IGF1R

(Homo

sapiens)

forward:

reverse:

TCGACATCCGCAACGACTATC-3’,

5’3’-

CCAGGGCGTAGTTGTAGAAGAG-5’. MCL1 (Homo sapiens) forward: 5’GACTTTTGGCCACCGGC-3’, reverse: 3’- GAGAGTCACAATCCTGCCCC-5’.
NAIP (Homo sapiens) forward: 5’-GCCTAGATGCAGTTCAGTTGG-3’, reverse: 3’GGCACCAAAGAGGATTAGGCT-3’.

XIAP

(Homo

sapiens)

forward:

5’-

GGTGAAGGAGATACCGTGCG-3’, reverse: 3’- GCATGTGTCTCAGATGGCCT5’. Nrf2 (Homo sapiens) forward: 5’- GAGACAGGTGAATTTCTCCCAA-3’, reverse:
3’- AACGTAGCCGAAGAAACCTCA-5’. β-Actin (Homo sapiens) forward: 5’reverse:

AGAAGGATTCCTATGTGGGCG-3’,
GGATAGCACAGCCTGGATAGCA-5’.

The

primers

were

3’synthesized

by

Integrated DNA Technologies, Inc. (IDT, Coralville, IA, USA). All assays were
carried out in triplicate. Relative quantitative analysis was performed by comparing
the threshold cycle number for target genes and a reference β-Actin mRNA.
Western blotting
Control and treated NCCs were washed twice with iced PBS and then lysed
in cold RIPA lysis buffer with 1 mM PMSF and protease cocktail inhibitor. Whole24

cell lysates were centrifuged at 12,000 x g for 10 min at 4˚C, and the supernatants
were used for Western blot. The protein concentration in each sample was
measured by using the BCA Protein Assay Reagent Kit (Pierce, Thermo Scientific,
Waltham, MA). The protein levels of Histone H3, acetyl-Histone H3, Histone H3
(tri methyl K4), cleaved caspase-3, E-cadherin, Vimentin, JARID1A, DNMT1,
DNMT3A, DNMT3B, HDAC1, HDAC2, HDAC3 and β-Actin were analyzed with the
following antibodies: anti-acetyl-Histone H3 rabbit pAb (06-799; Millipore,
Temecula, CA). anti-Histone H3 rabbit pAb (06-755; Millipore, Temecula, CA), antiHistone H3 (tri methyl K4) rabbit pAb (ab8580, Abcam, Cambridge, MA), anticleaved caspase-3 rabbit mAb (9661, Cell Signaling, Beverly, MA, USA), anti-Ecadherin rabbit mAb (14472, Cell Signaling, Beverly, MA, USA), anti-vimentin
rabbit mAb (5741, Cell Signaling, Beverly, MA, USA), anti-JARID1A rabbit mAb
(3876, Cell Signaling, Beverly, MA, USA), anti-DNMT1 rabbit mAb (5032, Cell
Signaling, Beverly, MA, USA), anti-DNMT3A rabbit mAb (32578, Cell Signaling,
Beverly, MA, USA), anti-DNMT 3B rabbit mAb (57868, Cell Signaling, Beverly, MA,
USA), anti-HDAC1 rabbit mAb (34589, Cell Signaling, Beverly, MA, USA), antiHDAC2 rabbit mAb (57156, Cell Signaling, Beverly, MA, USA), anti-HDAC3 rabbit
mAb (85057, Cell Signaling, Beverly, MA, USA). anti-β–Actin mouse mAb (Santa
Cruz, Santa Cruz, CA), respectively. Western blot was performed by standard
protocols, and the densitometry of the blot band was analyzed by ImageJ software
(National Institute of Health, USA). All Western blot analyses were performed in
triplicate.
ChIP-qRT-PCR analysis
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ChIP assay was performed using a ChIP assay kit (Millipore, Temecula, CA)
according to the manufacturer’s instruction. Briefly, NCCs from control and treated
groups were collected and cross-linked with 1% formaldehyde for 10 min at 37˚C,
and subjected to digest with SDS lysis buffer, then sonicated to shear DNA to the
length between 200 and 1000 bp using a Qsonica Q125 sonicator (QSonica,
Newtown, CT). The chromatin samples were diluted with ChIP dilution buffer and
immunoprecipitated using 1µg of H3K4me3 rabbit pAb antibody (Abcam,
Cambridge, MA) and mouse monoclonal (Ig)G (Santa Cruz, Santa Cruz, CA), used
as a negative control. Protein A agarose beads were added for precipitation and
then were washed and eluted, and DNA was purified for real-time PCR assay. For
DNA purification, the DNA was first treated with proteinase K to remove protein
and reverse the cross-links and was then purified by ChIP DNA clean &
Concentrator Kits (ZYMO Research, Irvine, CA). Quantitative real-time PCR was
performed on bound and input DNAs with the following primer pairs: Snail1 (Mus
musculus) P1 forward: 5’- GGCATCCCTGGGTAGTGTTTT-3’, reverse: 3’P2

GCATGTTGGCCAGAGCGAC-5’;

forward:

5’-

GAGCCCAAGCGGAATCTCAG-3’, reverse: 3’-GCATGTTGGCCAGAGCGAC-5’,
P3

forward:

5’-

reverse:

CACCTGCTCCGGTCTCAG-3’,

3’-

GCATGTTGGCCAGAGCGAC-5’, P4 forward: 5’- CAACAGTACGGTCACGCCC3’,

reverse:

3’-GCATGTTGGCCAGAGCGAC-5’,

P5

forward:

5’-

GCCTTGACAAAGGGGCGT-3’, reverse: 3’- GTCAAAGACACCCTCGGTGG-5’.
MCL1 (Homo sapiens) P1 forward: 5’- GAGAAGGCCCGAGGTGCTCATGGA-3’,
reverse:

3’-

TCCTACGGGGTGGCGCCAGCGA-5’;
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P2

forward:

5’-

reverse:

GTTACGTAACCGGCACTCAGAGC-3’,
P3

TCCTACGGGGTGGCGCCAGCGA-5’;

forward:
reverse:

CGGGCAGCTGGTAGGTGCCGT-3’,

3’5’3’-

TCCTACGGGGTGGCGCCAGCGA-5’. IGF1R (Homo sapiens) P1 forward: 5’reverse:

GGAGATGGGGGCGGCGCCTCGCA-3’,
P2

TCCTCGGGTTTTTTCCCTTTTT-5’;

reverse:

CCGGTTTTTTGCGCGCGCCGGCCT-3’,
P3

TCCTCGGGTTTTTTCCCTTTTT-5’;

forward:

forward:
reverse:

TGCGAGCGGGCGCGTGTGCGCGGG-3’,

3’5’3’5’3’-

TCCTCGGGTTTTTTCCCTTTTT-5’. BIRC6 (Homo sapiens) P1 forward: 5’reverse:

GGCCACGGCCGAACAGCTGCACC-3’,
P2

CCGGCGGGTGGAGCATGCGCG-5’;

reverse:

GGGCGTACCGGACAGGTCGCAAG-3’,
P3

CCGGCGGGTGGAGCATGCGCG-5’;

forward:

forward:
reverse:

TGCCCCCGCGAGGAGCGGGGCGG-3’,

3’5’3’5’3’-

CCGGCGGGTGGAGCATGCGCG-5’. AKT1 (Homo sapiens) P1 forward: 5’reverse:

GGCCGGGCTCCGTTAGCGGCCCAG-3’,
P2

TGCCCAGCGCTCGGTGCTCGGC-5’;

reverse:

CGAGCGCGCTCCGCCCTCGCCGCC-3’,
P3

TGCCCAGCGCTCGGTGCTCGGC-5’;
CGGCTCCGGGCGCGGGGCGGGCGC-3’,

forward:

forward:
reverse:

3’5’3’5’3’-

TGCCCAGCGCTCGGTGCTCGGC-5’. BIRC5 (Homo sapiens) P1 forward: 5’AGGCCTCTCAAAGTGTTGGGATTA-3’,
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reverse:

3’-

P2

GCGATTCAAATCTGGCGGTT-5’;

forward:
reverse:

GGGGGCGCTAGGTGTGGGCAGGGA-3’,
P3

GCGATTCAAATCTGGCGGTT-5’;

forward:
reverse:

CGCGGCGGGAGGACTACAACTCCC-3’,

5’3’5’3’-

GCGATTCAAATCTGGCGGTT-5’. NAIP (Homo sapiens) P1 forward: 5’reverse:

GCATGCTGTTGTGATTTTCTAGGA-3’,
AGATCTCTCCCTTGTGAGGGGCTT-5’;

P2

reverse:

TGGAAAGCACATGGCATGTCAAGG-3’,
AGATCTCTCCCTTGTGAGGGGCTT-5’;

forward:

P3

forward:
reverse:

GATTAGGGTGGGGCGCCCAACCTT-3’,

3’5’3’5’3’-

AGATCTCTCCCTTGTGAGGGGCTT-5’. XIAP (Homo sapiens) P1 forward: 5’reverse:

TGACCTCCCGGCCGGGGGTGGGAG-3’,
CCCGCGGCGATCGGCTCGGTCCA-5’;

P2

reverse:

CGCCCGGTGTCTCTTTGAGGCCCT-3’,
CCCGCGGCGATCGGCTCGGTCCA-5’;
GGGCCGGCCGGTAGAGGCGCGTGA-3’,

forward:

P3

forward:
reverse:

3’5’3’5’3’-

CCCGCGGCGATCGGCTCGGTCCA-5’.
Methylated Specific PCR (MSP)
The methylation status of CpG island of all samples was determined by
MSP. CpG islands were predicted by Methyl Primer Express software (Life
Technologies, Grand Island, NY) using the following parameters: -CGI size 3002000 bp, C+Gs/ total base > 50%, CpG observed/CpG expected > 60%. Genomic
DNA was extracted from control and treated NCCs by using DNeasy® Blood &
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Tissue Kit (QIAGEN, Valencia, CA) according to the manufacturer’s instruction. 1
µg of genomic DNA was processed with the EpiTect® Bisulfite Kit (QIAGEN,
Valencia, CA), during which the methylated DNA is protected and unmethylated
cytosine is converted to uracil. The modified DNA was used as a template for PCR
using primers specific for the methylated (M pair) and unmethylated sequences (U
pair) (Table 1) and the methylated DNA and unmethylated DNA were amplified.
The PCR products were then separated on a 2% agarose gel. When the CpG sites
in the region analyzed by MSP were methylated, the methylated bands (M)
presented. The unmethylated (U) bands presented when the sites were
unmethylated. Both M and U bands were presented when the sites were partially
methylated.
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Table1: Primer sets of ten anti-apoptotic genes used for MSP.
Methylation Specific Primers

Unmethylation specific primers

Product
size(bp)

Forward

5'-AGTATCGAGCGTTGGGTATC

5'-GAGTATTGAGTGTTGGGTATT

167

Reverse

3'-GAACGCGAACCTAACCGA

3’-CAAACACAAACCTAACCAA

167

BCL2

Forward

5'-TTAAAATTGTTTGTTTGCGC

5'-ACCGTCCTAACGCTAAAATAAA

155

CpG 1

Reverse

3'

5'CCCACCATCCTAACACTAAAATAAA

155

Gene
AKT1

AATTTAAAATTGTTTGTTTGTGT
BCL2

Forward

5'AGTTGTCGTAGAGGGGTTAC

5'-ATAAGTTGTTGTAGAGGGGTTAT

156

Reverse

3'-TCTACAACGACGAAATCCT

3'-TCTACAACAACAAAATCCTAAC

156

Forward

5'-CGCGTTTTTTGAAAGTAGTC

5’- GTATGTGTTTTTTGAAAGTAGTT

227

Reverse

3'-TCTAACGATTAATAACGCGC

3'-AATCTAACAATTAATAACACACC

227

Forward

5'-GTATGTATTGCGACGTCGAC

5'- GTTGTATGTATTGTGATGTTGAT

119

Reverse

3'-TATAACCCCCGAAATACCG

3'-CAATATAACCCCCAAAATACCA

119

IGF1R

Forward

5'-GGTTTTACGGTCGTAACGTC

5'-GGGTTTTATGGTTGTAATGTT

126

CpG 1

Reverse

3'-CGTACTAAAAAACCCGAACG

3'-ACATACTAAAAAACCCAAACA

126

IGF1R

Forward

5'-AGTTTTGGGTCGTTGTTGTC

5'-GAGTTTTGGGTTGTTGTTGTT

100

CpG 2

Reverse

3'-ACAATACTCCGAAAACGACG

3'-AACAATACTCCAAAAACAACA

100

MCL1

Forward

5'-GGTACGAGTCGGAGTTTTTC

5'-GGGTATGAGTTGGAGTTTTTT

192

Reverse

3'-CGATAACCTACTCCCGAAAA

3'-CCAATAACCTACTCCCAAAAA

192

Forward

5'-AGGTTGGAGTATCGTGGC

5'-TTTAGGTTGGAGTATTGTGGT

118

Reverse

3'-GAACGTAATAACGAACGCCT

3’- ACCAAACATAATAACAAACACCT

118

Forward

5'GGCGGAGGTTGTAGTGAGTC

5'GGAGGTGGAGGTTGTAGTGAGTT

114

Reverse

3'-ATAAACATAAACCACCGCGC

3'TATAAACATAAACCACCACACCC

114

CpG2
BIRC5

BIRC6

NAIP

XIAP

siRNA transfection
KDM5A siRNA (SMART pool: ON-TARGET plus mouse KDM5A), HDAC2
(SMART pool: ON-TARGET plus human HDAC2), and DNMT3A (SMART pool:
ON-TARGET plus human DNMT3A) were purchased from Dharmacon (Lafayette,
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CO). Each 5 nmol stock siRNA was reconstituted into 10 µM aliquots. Scramble
control siRNA (siCon) was purchased from Integrated DNA Technologies
(Coralville, IA). For siRNA transfection, NCCs were seeded at 125,000 cells/per
well in 12-well plates and transfected with siRNA or siCon in a final concentration
of 25 nM by using lipofectamineTM2000 (Thermo Fisher, Waltham, MA), according
to manufacturer’s instruction. 24 hours post-transfection, the cells were harvested
at 24 hours after transfection for experiments.
Analysis of apoptosis
Apoptosis in NCCs was determined by the analysis of cleavage of caspase3 and the flow cytometry analysis of Annexin V staining. Caspase-3 cleavage was
determined by Western blot, as described previously 17. The number of apoptotic
cells was determined by flow cytometry using a FITC Annexin V apoptosis
detection kit (BD Bioscience, Franklin Lakes, NJ, USA), following the
manufacturer’s instruction. Briefly, control and treated NCCs were collected,
washed twice with PBS, resuspended in binding buffer, and then incubated with
Annexin V and PI for 15 min. The apoptotic cells were detected using a
FACSCalibur flow cytometer (BD Bioscience, Franklin Lakes, NJ, USA.)
The whole-mount TUNEL staining of embryos for detection and
quantification of the apoptotic cells in zebrafish was performed using the TMR red
in situ Detection Kit (Millipore, Temecula, CA). The embryos were fixed overnight
in 4% paraformaldehyde in PBS at 4˚C. Samples were dehydrated with 100%
methanol overnight, then rehydrated in successive dilutions of methanol (100%,
75%, 50%, 25%, 0%) in PBS. The embryos were then permeabilized with
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proteinase K (20 µg/mL in PBST) at room temperature for 10 min., followed by profixation in 4% PFA-PBS at room temperature for 20 min. The samples were then
washed five times with PBST for 5 min each and incubated in 50 µL of TUNEL
reaction mixture (5 µL of enzyme solution+ 45 µL label solution) in the dark at 37˚C
for 2 hours. The reaction was stopped by washing the samples five times for 5 min
each in PBST. Following the staining, embryos were visualized in the green
channel of a fluorescent microscope (SZX16, Olympus, USA).
Statistical analysis
Statistical analyses were performed using GraphPad Prism software
(GraphPad Software, San Diego, CA, USA). All data were expressed as mean ±
SEM of at least three independent experiments. Comparisons between groups
were analyzed by one-way ANOVA. Multiple comparison post-tests between
groups were conducted using Bonferroni’s test. Differences between groups were
considered significant at p < 0.05.

32

CHAPTER III
SULFORAPHANE PROTECTS AGAINST ETHANOL-INDUCED APOPTOSIS IN
HUMAN NEURAL CREST CELLS THROUGH DIMINISHING ETHANOLINDUCED HYPERMETHYLATION AT THE PROMOTERS OF THE ANTIAPOPTOTIC GENES
Introduction
Prenatal alcohol exposure can cause a spectrum of physical abnormalities and
mental dysfunctions in children, which are defined as FASD128,

129

. Previous

studies by Kotch and Sulik, as well as Dunty et al., have revealed that acute
exposure to ethanol during gastrulation resulted in excessive cell death in neural
crest cells (NCCs)14, 130. Using a chick-specific antibody to NCCs, Cart Wright and
Smith confirmed that the regions of ethanol-induced apoptosis are premigratory
cranial neural crest131. Studies from our laboratory have also shown that ethanol
increased apoptosis in NCCs and that ethanol-induced apoptosis in NCCs
contributes heavily to ethanol-induced malformations132,

133

. However, the

molecular mechanisms underlying the apoptosis that result from alcohol exposure
are poorly understood. It is well-known that ethanol can induce modifications in
DNA22-24 and histones25, 27-29, and such changes may mediate some detrimental
effects of prenatal alcohol exposure and contribute to the abnormalities associated
with FASD. An earlier study by Garro has shown that the fetal DNA was
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hypermethylated after ethanol exposure during embryonic development 30.
Hypermethylation in the promoter regions of genes is associated with gene
repression134. DNA hypermethylation is associated with the repression of many
genes involved in various cellular functions, including DNA repair, cell adhesion,
and apoptosis40, 135. DNA methylation has been shown to be associated with the
repression of the apoptotic genes in cancer cells, which are known to avoid
apoptosis39, 136, 137. Hypermethylation in the Casp 8 promoter was correlated with
a low Casp 8 expression, conferring apoptosis resistance in different cancer cell
lines, such as pediatric cancer138, lung carcinomas139 and breast cancers140. In
contrast, hypermethylation at the promoters of the anti-apoptotic genes, including
Bcl2 is associated with the down-regulation of Bcl2 gene expression and
apoptosis141. These studies suggest that epigenetic regulation of apoptosis-related
genes by modulating DNA methylation may contribute to the ethanol-induced
apoptosis and the pathogenesis of FASD.
DNA methylation occurs on the cytosine residue of CpG dinucleotides through
the transfer of 5-methylcytosine from the methyl donor S-adenosylmethionine
(SAM) to the CpG. The reaction is catalyzed by a family of enzymes called DNA
methyltransferases (DNMT), including DNMT1, DNMT3a and DNMT3b142. DNMT1
is responsible for the maintenance of established patterns of DNA methylation,
while DNMT3a and DNMT3b mediate the establishment of new or de novo DNA
methylation patterns143, 144. Alteration of DNA methylation by DNMT may trigger
hypermethylation or hypomethylation of gene promoters and consequently result
in activating or inhibiting gene expression, which can be reversed by DNMT
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inhibitor. Evidence from literature indicates that aberrant methylation of antiapoptotic genes by DNMT inhibitor may be involved in apoptosis resistance 39, 46.
Studies have shown that loss of methylation induced by DNMT inhibitor at the
promoters of the IAP gene related to apoptosis resistance39. These results
indicated that DNMTi may prevent apoptosis by regulating DNA methylation at the
promoters of apoptosis-related genes.
Sulforaphane (SFN) is a vegetable-derived isothiocyanate that is abundant in
cruciferous vegetables such as broccoli. Our previous studies have shown that
SFN prevented ethanol-induced apoptosis through upregulating the anti-oxidant
gene Nrf2 in NCCs17. In addition to acting as Nrf2 inducer, SFN has been found to
regulate gene expression by inhibiting the activity of DNMTs, the enzymes involved
in DNA methylation145. SFN was also found to inhibit LPS-induced DNMT3a gene
expression, conferring resistance to LPS-induced apoptosis in porcine monocytederived dendritic cells146.
In the present study, I tested the hypothesis that SFN can reverse ethanolinduced apoptosis through epigenetic upregulation of the anti-apoptotic genes. I
observed that eight anti-apoptotic genes (AKT1, Bcl2, BIRC5, BIRC6, IGF1R,
MCL1, NAIP and XIAP) are repressed by ethanol and de-repressed by SFN in
hNCCs. I also found that SFN can inhibit the enzymatic activity of DNMT in ethanol
exposed hNCCs. SFN also diminished ethanol-induced upregulation of DNMT3a.
Among eight anti-apoptotic genes, Bcl2, XIAP, BIRC5, BIRC6, and XIAP were
hypermethylated by ethanol, which can be prevented by SFN treatment.
Knockdown of DNMT3a significantly reversed ethanol-induced inhibition of NAIP
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and XIAP expression and enhanced SFN’s effects on the mRNA and protein
expression of NAIP and XIAP in hNCCs. I also found that SFN can prevent ethanolinduced apoptosis by diminishing ethanol-induced upregulation of DNMT3a in
hNCCs. These results demonstrate that SFN can prevent the ethanol-induced
apoptosis by diminishing the ethanol-induced hypermethylation at the promoters
of the anti-apoptotic genes in hNCC.
Experimental procedures
Cell treatment
hNCCs or NCCs were pretreated with or without 1µM SFN for 24 hours,
followed by concurrent exposure to 1µM SFN and 50 mM ethanol for an additional
24 hours. Cell culture dishes were placed in a plastic desiccator containing 50 mM
ethanol in distilled water to maintain the stable ethanol levels
MTS cell viability assay
Cells were seeded in a 96-well microtiter plate in a final volume of 200
µL/well. For determining the dose-response effects of ethanol on cell viability,
NCCs were treated with or without 25, 50, 100 mM ethanol for 24 hours. For
determining the dose-response of SFN on ethanol-induced changes in cell viability,
NCCs were treated with 0.5, 1, 2, 4 µM SFN for 24 hours, followed by 24 hours of
concurrent exposure to SFN and 50 mM ethanol. After treatment, 20 µL /well MTS
Reagent (Promega, Madison, WI) was added into each well and incubated for 1-4
hours at 37 ºC in standard culture conditions. The quantity of the formazan product
was measured at 490 nm using a plate reader.
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Western blot
The protein expression levels of DNMT1, DNMT3a, DNMT3b, cleaved
caspase-3, NAIP and XIAP were determined by Western blot, as described in
Chapter II, C.
Expression profiling of apoptosis-related genes using human
apoptosis PCR array
The human RT2 Profiler PCR array was purchased from Qiagen (Valencia,
CA). RNAs were isolated from control and treated cells, then cDNA was
synthesized as described in Chapter II, Section C. 2. The PCR mixture
components were prepared by adding the 2X RT2 SYBR Green Mastermix, cDNA
synthesis reaction and RNase-free water and mixing well. The PCR mixture
components were dispensed into the RT2 Profiler PCR array and, then proceed the
plate to the RT-PCR machine.
Quantitative real-time PCR
mRNA expression of AKT1, BCl2, BIRC5, BIRC6, IGF1R, MCL1, NAIP,
XIAP and β-actin were measured by quantitative real-time RT-PCR, as described
in Chapter II, Section C. 2.
Analysis of DNMT activity
hNCCs from the control and treated groups were harvested, and nuclear
extracts were isolated by using the EpiQuik Nuclear Extraction Kit (Epigentek)
according to the manufacturer’s protocol. The protein concentrations of nuclear
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extraction were measured using the BCA protein assay kit (Thermo Scientific). 20
µg of nuclear extracts were used to determine the DNMT enzymatic activity, and
the absorbance was read on a microplate reader at 450 nm. The DNMT activity
was calculated using the following formula:
DNMT activity (OD/h/mg) = (sample OD-Blank OD)/ (µg protein amount x hour)
x1000
Statistical analysis
Statistical analysis was performed as described in Chapter II, Section D.
Results
Differentiation of hNCCs from hESCs.
hNCCs were differentiated from hESCs using the protocol described in
Chapter II, section A. hNCCs were validated by the immunocytochemistry using
the hNCC marker HNK1. The result of immunocytochemistry indicated that all
hNCCs are positive for the hNCC marker HNK1 (Figure 3.1).
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Figure 3. 1. Differentiation of hNCCs from hESCs. Immunocytochemistry analysis
shows that hNCCs are positive for the NCC marker HNK1.
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Ethanol treatment significantly increased apoptosis in hNCCs.
To determine whether ethanol exposure can decrease cell viability and
increase apoptosis in hNCCs, hNCCs were exposed to 25, 50 or 100 mM ethanol
for 24 hours. The cell viability was analyzed using the MTS assay. As shown in
Figure 3.2A, 50 or 100 mM ethanol significantly reduced cell viability in hNCCs.
Ethanol exposure also resulted in a dose-dependent manner, as indicated by the
significant increase in caspase activation (Figure 3.2B).
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Figure 3. 2. Ethanol exposure significantly reduced cell viability and increased
apoptosis in hNCCs. hNCCs were exposed to 25, 50 or 100 mM ethanol for 24 h.
Cell viability was determined by using the MTS assay (A). Apoptosis was analyzed
by analysis of cleaved caspase-3 by western blotting (B). Data are expressed as
a percentage of control (A) or fold change over control and represent the mean ±
SEM of three separated experiments. *p<0.05, **p<0.01.
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SFN treatment prevented ethanol-induced apoptosis in hNCCs.
To determine whether SFN can reduce ethanol-induced reduction in cell
viability in hNCCs, the cells were treated with ethanol or/and SFN at different
concentrations for 24 hours. As shown in Figure 3.3A, SFN at 1 µM significantly
diminished the reduction of cell viability in hNCCs exposed to 50 mM ethanol.
Treatment with SFN also significantly reduced caspase-3 activation in hNCCs
exposed to ethanol (Figure 3.3B).
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Figure 3. 3. SFN prevented the ethanol-induced reduction of cell viability and
apoptosis in hNCCs. (A) hNCCs were treated with 50 mM ethanol alone or cotreated with SFN at the indicated concentration for 24 hours. Cell viability was
determined by MTS assay. (B) hNCCs were exposed to 1 µM SFN for 24 h,
followed by concurrent exposure to 1 µM SFN and 50 mM ethanol for 24 h.
Apoptosis was determined by the analysis of caspase-3 cleavage using western
blotting. Data are expressed as a percentage of control (A) or fold change over
control (B) and represent the mean ± SEM of three separated experiments.
*p<0.05, **p<0.01.
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Identification of anti-apoptotic genes that are repressed by ethanol
and that their repression by ethanol can be prevented by SFN in
hNCCs.
To identify the anti-apoptotic genes that were repressed by ethanol and derepressed by SFN in hNCCs, the RT2 human apoptosis array was used to profile
the expression of apoptosis-related genes. The gene expression in hNCCs was
depicted by the heat map with upregulation in red and downregulation in green
(Figure 3.4A). The quantification of the heatmap was shown in Figure 3.4B. We
have identified eight anti-apoptotic genes that were down-regulated by ethanol and
that their down-regulation can be prevented by SFN, including AKT1, BCL2, BIRC5,
BIRC6, IGF1R, MCL1, NAIP and XIAP. The results from human apoptosis array
were validated by quantitative RT-PCR (Figure 3.4C).
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Figure 3. 4. Identification of the anti-apoptotic genes that are repressed by ethanol
and de-repressed by SFN. hNCCs were pre-treated with 1µM SFN for 24 hours
and then co-treated with 1µM SFN and 50 mM ethanol for another 24 hours. The
RT2 apoptosis array was used to profile the apoptosis-related genes expression in
control and treated hNCCs, and the mRNA expression of 84 apoptosis-related
genes was depicted by the heat map (A). Eight anti-apoptotic genes were identified
from apoptosis array analysis (B). The mRNA expression of the selected antiapoptotic genes was validated using RT-PCR (C). The data were expressed as
fold change over control and represent the mean ± SEM of three separated
experiments. *p < 0.05.
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SFN diminished ethanol-induced increase in DNMT activity and upregulation of DNMT3a in hNCCs.
To determine the effects of ethanol and SFN on the activity of DNMT,
hNCCs were pretreated with SFN for 24 hours, then co-treated with SFN and
ethanol for another 24 hours. As shown in Figure 3.5A, treatment with SFN
significantly reduced the ethanol-induced increase in the activity of DNMT in
hNCCs. Three enzymatically active DNMTs, includingDNMT1, DNMT3a and
DNMT3b, were involved in DNA methylation in eukaryotic cells38,
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. We thus

examined the protein expression of DNMT1, DNMT3a and DNMT3b by Western
blot in hNCCs. As shown in Figure 3.5B, while ethanol exposure did not
significantly change the protein expression of DNMT1 and DNMT3b, ethanol
exposure significantly increased the expression of DNMT3a in hNCCs. Cotreatment with SFN and ethanol reduced ethanol-induced increase in DNMT3a
expression. This result suggested that DNMT3a may be the primary
methyltransferase responsible for ethanol-induced hypermethylation at the
promoters of anti-apoptotic genes in hNCCs.
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Figure 3. 5. Co-treatment with SFN and ethanol reduced DNMT activity and
DNMT3a expression in ethanol exposed hNCCs. hNCCs were treated with 1 µM
SFN for 24 hours, then co-treated with 1 µM SFN and 50 mM ethanol for an
additional 24 hours. (A) Treatment SFN significantly reduced the ethanol-induced
increase in the activity of DNMT in hNCCs (B) Co-treatment with SFN and ethanol
significantly decreased the ethanol-induced increase in DNMT3a protein
expression in hNCCs. Data are expressed as fold change over control and
represent the mean ± SEM of three separated experiments. *p<0.05.
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SFN diminished the ethanol-induced hypermethylation at the
promoters of the selected anti-apoptotic genes in hNCCs.
To determine whether ethanol-induced up-regulation of DNMT3a and
increase in DNMT activity can result in hypermethylation at the promoters of the
selected anti-apoptotic genes and whether SFN that can prevent ethanol-induced
up-regulation of DNMT3a and increase in DNMT activity can diminish ethanolinduced hypermethylation at the promoters of anti-apoptotic genes, the
methylation of CpG islands at the promoters of the identified anti-apoptotic genes
in human NCCs was analyzed by using methylation-specific PCR (MSP).
Exposure to ethanol resulted in a significant increase in the methylation level at
the promoters of Bcl2, XIAP, BIRC5, BIRC6 and NIAP. Co-treatment with SFN
significantly diminished ethanol-induced hypermethylation at the promoters of
these anti-apoptotic genes in human NCCs (Figure 3.6). These results
demonstrated that ethanol exposure can induce hypermethylation at the promoters
of the selected anti-apoptotic genes in hNCCs, which can be prevented by cotreatment with SFN.
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Figure 3. 6. SFN significantly diminished the ethanol-induced hypermethylation at
the promoters of Bcl2, XIAP, BIRC5, BIRC6 and NAIP in hNCCs. hNCCs were
pre-treated with 1 µM SFN for 24 hours and then continue to be exposed in medium
containing SFN, ethanol, or in combination for 24 hours. (A) Schematic illustration
of the CpG sites and CpG island in the promoter of the anti-apoptotic gene. (B)
DNA methylation status at the CpG island of the selected anti-apoptotic genes was
determined by using MSP. Data are expressed as fold change over control and
represent the mean ± SEM of three separated experiments. *p < 0.05. M:
methylated DNA, U: unmethylated DNA.
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Knockdown of DNMT3a and SFN treatment significantly diminished
ethanol-induced down-regulation of NAIP and XIAP in hNCCs
To further confirm that DNMT3a is responsible for the ethanol-induced
hypermethylation at the promoters of anti-apoptotic genes and subsequent downregulation of these genes, DNMT3a was knocked down by siRNA in hNCCs before
treatment with ethanol and SFN. We found that ethanol exposure significantly
decreased mRNA expression of NAIP and XIAP. Protein expression of NAIP and
XIAP was also decreased in ethanol-exposed hNCCs. The knockdown of DNMT3a
or treatment with SFN significantly diminished ethanol-induced decreases in the
mRNA and protein expression of NAIP and XIAP. In addition, knockdown of
DNMT3a enhanced the effects of SFN on the mRNA and protein expression of
NAIP and XIAP (Figure 3.7A, B). These results indicated that either knockdown of
DNMT3a or inhibition of DNMT activity by SFN can diminish ethanol-induced
repression of anti-apoptotic genes in hNCCs.
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Figure 3. 7. Knockdown of DNMT3a and SFN treatment significantly diminished
ethanol-induced down-regulation of NAIP and XIAP in hNCCs. hNCCs transfected
with control-siRNA or DNMT3A-siRNA were treated with 1µM SFN or 50 mM
ethanol or co-treated with ethanol and SFN for further 24 hours. (A) The mRNA
expression of NAIP and XIAP was determined by quantitative RT-PCR. (B) The
protein expression of NAIP and XIAP was determined by western blotting. Data
are expressed as fold change over control and represent the mean ± SEM of three
separated experiments. *p < 0.05, **p<0.01.
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Knockdown of DNMT3a and SFN treatment prevented ethanol-induced
apoptosis in hNCCs.
To determine whether ethanol-induced up-regulation of DNMT3a and
subsequent hypermethylation at the promoters of the selected anti-apoptotic
genes and repression of these genes contribute to ethanol-induced apoptosis and
whether SFN can prevent ethanol-induced apoptosis by diminishing ethanolinduced up-regulation of DNMT3a, DNMT3a was knocked down by siRNA in
hNCCs. Apoptosis was determined by the analysis of caspase-3 activation using
western blot. I found that ethanol exposure significantly increased apoptosis in
hNCCs. The knockdown of DNMT3a by siRNA or down-regulation of DNMT3a by
SFN significantly diminished ethanol-induced apoptosis in hNCCs (Figure 3.8).
These results demonstrate that ethanol-induced up-regulation of DNMT3a
contributes to ethanol-induced apoptosis and that SFN can prevent ethanolinduced apoptosis in hNCCs by diminishing ethanol-induced up-regulation of
DNMT3a.
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Figure 3. 8. Knockdown of DNMT3a and SFN treatment prevented ethanolinduced apoptosis in hNCCs. hNCCs transfected with siRNA-DNMT3a or siRNAcontrol were treated with1 µM SFN or 50 mM ethanol or co-treat with SFN and
ethanol for 24 hours. The protein expression of DNMT3a and cleaved caspase-3
were determined by western blotting. Data are expressed as fold change over
control and represent the mean ± SEM of three separated experiments. *p < 0.05,
**p<0.01, ***p<0.001.
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D. Discussion
Ethanol-induced apoptosis in hNCCs is one of the major mechanisms
underlying the pathogenesis of FASD. Studies have shown that epigenetic
modifications contribute to the harmful consequences of alcohol abuse during
pregnancy in the developing fetus35. Epigenetic modifications, such as altered
DNA methylation and histone modifications, are thought to influence apoptosisrelated genes in response to ethanol exposure. Recent studies in our laboratory
have demonstrated that ethanol exposure significantly increased apoptosis
through decreasing histone acetylation on the promoter of the anti-apoptotic gene,
Bcl218. However, the role of DNA methylation in the ethanol-induced apoptosis has
not been well elucidated. In this study, I determined whether ethanol exposure can
increase apoptosis through epigenetically repressing the anti-apoptotic genes and
whether SFN, a well-known epigenetic regulator, can epigenetically de-repress the
anti-apoptotic gene expression. I found that treatment with ethanol significantly
repressed the expression of AKT1, Bcl2, BIRC5, BIRC6, IGF1R, MCL1, NAIP and
XIAP. SFN treatment diminished ethanol-induced repression of these genes in
hNCCs. Treatment with SFN also significantly reduced ethanol-induced increase
in the enzymatic activity of DNMT in hNCCs. In addition, SFN treatment
significantly reduced the ethanol-induced hypermethylation at the promoters of
BIRC5, BIRC6, NAIP, XIAP and Bcl2, suggesting that the aberrant DNA
methylation induced by ethanol contributes to the downregulation of the antiapoptotic genes in ethanol-exposed hNCCs.
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To further explore the molecular mechanisms by which ethanol induces the
aberrant methylation at the promoters of the anti-apoptotic genes, I analyzed the
protein levels of DNMT1, DNMT3a and DNMT3b, which are the main enzymes
involved in DNA methylation in mammals142. DNMT1 contributes to maintaining
the established DNA methylation patterns. DNMT3a and DNMT3b are known as
de novo methyltransferase and play a role in the establishment of methylation
patterns during development148. In addition, the defect of DNMT3a was reported
to result in nonprogressive neurodevelopmental conditions 149. Interestingly,
environmental stimuli, like stress, in the pregnant rat has been found to increase
DNMT3a expression and alter DNA methylation levels in their offspring150. Study
has also demonstrated that ethanol exposure increased the expression of
DNMT3a in rats151. Consistent with these findings, I observed that ethanol
treatment increased the expression of DNMT3a, which can be diminished by
treatment with SFN in hNCCs, indicating that upregulation of DNMT3a contributes
to ethanol-induced hypermethylation at the promoters of anti-apoptotic genes and
that SFN can diminish ethanol-induced hypermethylation at the promoters of antiapoptotic genes by reducing ethanol-induced up-regulation of DNMT3a. Our
observation is consistent with the study from Qu X et al., which has shown that
SFN decreased DNMT3a gene expression in porcine monocyte-derived dendritic
cells146.
Studies from others have demonstrated that DNMT3a can regulate apoptosisrelated genes expression in cancer cells through changing the methylation level at
the promoter region of the apoptosis-related genes, such as Bad, Bax and Bcl2152-
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154

. In the present study, I have found that knockdown of DNMT3a by transfected

with siRNA-DNMT3a significantly reduced the ethanol-induced down-regulation of
NAIP and XIAP. The knockdown of DNMT3a also enhanced SFN’s effects on
promoting the expression of NAIP and XIAP in ethanol-exposed hNCCs. These
results suggest that the upregulation of DNMT3a contributes to ethanol-induced
down-regulation of anti-apoptotic genes, NAIP and XIAP, by inducing
hypermethylation at the promoters of these genes.
It has been reported that DNMT inhibitor-induced aberrant methylation at the
promoters of the anti-apoptotic genes, including ciAP1, ciAP2, Survivin, NAIP and
XIAP, might be related to apoptosis resistance in cancer cells39. As a DNMT
inhibitor, SFN has also been shown to promote cell survival in a dose and cell typedependent manner. For instance, the study by Qu et al., indicated that SFN
suppressed the LPS-induced apoptosis in monocyte-derived dendritic cells
through down-regulating DNMT3a and the suppression of TGF-β signaling146.
Additionally, previous studies in our laboratory have demonstrated that SFN can
promote cell survival by upregulating the anti-apoptotic gene, Bcl2, in ethanol
exposed NCCs18. Treatment with SFN also significantly diminished the ethanolinduced reduction of Snail1, conferring resistance to apoptosis in NCCs 133. In the
present study, I found that knockdown of DNMT3a significantly decreased
caspase-3 activation in ethanol-exposed hNCCs and enhanced SFN’s protective
effects on ethanol-induced apoptosis, suggesting that inhibition of DNMT3a
contributes to SFN’s protective effects on the ethanol-induced apoptosis in hNCCs.
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In summary, the present study indicated that ethanol treatment can inhibit the
expression of the anti-apoptotic genes, including AKT1, Bcl2, BIRC5, BIRC6,
IGF1R, MCL1, NAIP and XIAP and that ethanol-induced repression of these antiapoptotic genes can be prevented by SFN. I also observed that SFN diminished
ethanol-induced up-regulation of DNMT3a and an increase in the enzymatic
activity of DNMT. Ethanol exposure also resulted in hypermethylation at the
promoters of the selected anti-apoptotic genes, including BIRC5, BIRC6, NAIP,
XIAP and Bcl2, which can be prevented by SFN treatment. Knockdown of DNMT3a
and SFN also significantly diminished the ethanol-induced down-regulation of
NAIP and XIAP, and subsequently conferring protection against ethanol-induced
apoptosis in hNCCs. These findings suggest that SFN may represent a promising
and effective agent for the prevention of ethanol-induced apoptosis and FASD.
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CHAPTER IV
SULFORAPHANE PREVENTS HUMAN NEURAL CREST CELLS FROM
ETHANOL-INDUCED APOPTOSIS THROUGH DIMINISHING ETHANOLINDUCED REDUCTION OF HISTONE ACETYLATION AT THE
PROMOTER OF THE ANTI-APOPTOTIC GENES
Introduction
Maternal ethanol exposure during pregnancy could result in physical and
behavioral abnormalities in the offspring, which is defined as fetal alcohol spectrum
disorder (FASD)128,

129, 155

. Exposure of mouse or chicken embryos to ethanol

during a certain period of development can also cause craniofacial abnormalities
associated with FASD14, 131, 156. Extensive research with mice or chicken embryos
revealed that exposure to ethanol could induce excessive cell death in neural crest
cells (NCCs)130, 157, 158. Studies in our lab also shown ethanol exposure increased
apoptosis in NCCs and that ethanol-induced apoptosis in NCCs contributes heavily
to ethanol-induced malformations132, 133. The molecular mechanisms underlying
FASD that result from prenatal alcohol exposure are poorly understood. Studies
have shown that ethanol can induce modifications in DNA22-24 and histones25, 27-29,
and such changes may mediate the detrimental effects of prenatal alcohol
exposure and contribute to the abnormalities associated with FASD. The first study
on the role of histone modification in alcohol-induced damages was conducted on
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liver cells. This study found that H3K9ac was increased in a time- and dosedependent manner after ethanol exposure159, 160. Furthermore, it has also been
reported that chronic alcohol exposure in humans resulted in global increases in
the levels of histone 3 at lysine 4 (H3K4me3) 161. Histone acetylation and
methylation play a critical role in the regulation of the expression of the genes
involved in cell cycle progression and apoptosis162, 163. For instance, study has
shown that prenatal alcohol exposure decreased histone H3K9 acetylation at the
promoter regions of the anti-apoptotic gene Bcl2, resulting in the downregulation
of Bcl2 and apoptosis in fetal myocyte164. Taken together, these works indicated
that ethanol-induced epigenetic modulation of apoptosis-related genes could be
an important mechanism underlying the pathogenesis of FASD.
The complexes of nuclear DNA and proteins are called chromatin. In
chromatin, the fundamental repeat unit is the chromosome, consisting of one
octamer comprised of four core histone proteins (H2A, H2B, H3 and H4) around
which 147 base pairs of DNA are wrapped48. Each of the core histones has an Nterminal “tail” that can be subject to several covalent modifications associated with
euchromatic (open) and heterochromatin (close) chromatin states. These covalent
modifications

are

methyltransferases

established
(KMTs),

by

“writers”,

histone

such

as

acetyltransferases

histone

lysine

(HATs).

These

modifications can be removed by “erasers,” such as histone demethylases (KDMs),
histone deacetylases (HDACs)165. HATs and HDACs are associated with histone
acetylation and deacetylation, representing transcriptional activation or repression,
respectively166, 167. There are 18 HDACs in human, and they are distributed into 4
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classes: class I HDACs (1, 2, 3 and 8), class II HDACs (4, 5, 6, 7 and 9), and class
IV HDACs are all dependent upon zinc for activity, whereas class III HDACs are
structurally unique because they need NAD+ for enzymatic activity 168,

169

. The

histone deacetylase inhibitor (HDACi) can interfere with the deacetylase function
of HDAC, improving the acetylation of histone and activating gene expression.
Substantial studies have indicated that the HDACi are emerging as a prominent
class of therapeutic agents for the treatment of a variety of cancers, such as
pancreatic, ovarian, breast, colon, prostate, and thyroid cancer59-62. Other studies
have also demonstrated that HDACi has important neuroprotective effects in the
prevention or treatment of nervous system diseases64-66. HDACi is also known to
inhibit apoptosis, increase cell survival and enhance anti-inflammatory response64,
65, 68, 69

. The study from Dr. Zhang has shown that the HDACi valproic acid (VPA)

protected against neuronal apoptosis by activating BNDF-TrkB signaling at the
transcriptional level, VPA treatment also resulted in the hyperacetylation of histone
H3K14 at the promoter regions of BNDF, and promoted transcriptional activity71.
VPA has also been shown to upregulate the expression of anti-apoptotic gene
Hsp70 by enhancing the acetylation of histone H3 at Hsp70 promoter 68. These
results demonstrate that HDACis might be used as protective agents to regulate
the apoptosis-related genes and prevent ethanol-induced apoptosis.
Sulforaphane (SFN) is a vegetable-derived isothiocyanate that is abundant in
cruciferous vegetables such as broccoli. Compelling evidence indicated that SFN
can prevent cancer and other diseases through its regulatory role on the tumor cell
cycle, apoptosis and angiogenesis112,

170-172

. Interestingly, our previous studies
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have shown that SFN exerts an anti-apoptotic effect through upregulating the antioxidant gene Nrf2 in NCCs17. Recent studies have shown that SFN can inhibit
HDACs, the enzyme involved in histone deacetylation115, 117, 173. Moreover, some
other study has shown the metabolite of SFN, SFN-cysteine, can interact with the
active site of HDAC, which subsequently inhibits HDAC activity174. SFN was found
to inhibit LPS-induced HDAC6, HDAC10 and DNMT3a gene expression,
conferring resistance to LPS-induced apoptosis in porcine monocyte-derived
dendritic cells146. Our recent study has also shown SFN can prevent ethanolinduced apoptosis in NCCs by diminishing ethanol-induced reduction of histone
acetylation at the promoter of the anti-apoptotic gene, Bcl218. We have also
demonstrated that SFN treatment prevented the ethanol-induced reduction of
H3K4me3 on the promoters of Snail1, a key transcriptional factor of epithelial to
mesenchymal transition (EMT), and prevented ethanol-induced apoptosis in
NCCs133.
In the present study, I tested the hypothesis that SFN can reverse ethanolinduced apoptosis through epigenetic upregulation of the anti-apoptotic genes. I
found that SFN can diminish the ethanol-induced increase in the enzymatic activity
of HDAC and up-regulation of HDAC2. Treatment with SFN also diminished
ethanol-induced reduction of H3 acetylation at the promoters of AKT1, BIRC6 and
XIAP, resulting in increased expression of AKT1, BIRC6 and XIAP in ethanol
exposed hNCCs. Knockdown of HDAC2 can also prevent ethanol-induced
repression of these genes, enhancing SFN’s protective effects on the expression
of anti-apoptotic genes in ethanol-exposed hNCCs. I have also demonstrated that
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SFN and knockdown of HDAC2 can protect hNCCs against ethanol-induced
apoptosis. These results demonstrate that SFN can significantly prevent ethanolinduced apoptosis in hNCCs through epigenetically upregulating the anti-apoptotic
genes.
Experimental Procedures
Cells treatments
hNCCs were pretreated with or without 1 µM SFN for 24 hours, followed
by concurrent exposure to 1 µM SFN and 50 mM ethanol in a plastic desiccator
containing 50 mM ethanol in distilled water.
ChIP-qRT-PCR analysis
ChIP experiments were performed as described in Chapter II, C. 4.
Chromatin was immunoprecipitated with antibodies to H3ac. The qPCR was
carried out with primers shown in Chapter II, C.4.µµ
Quantitative real-time PCR
mRNA expression of AKT1, BIRC6, and XIAP were measured by
quantitative RT-PCR, as described in Chapter II, Section C. 2.
Western Blotting
The protein level of H3Ac, Cleaved caspase-3, HDAC1, HDAC2, HDAC3,
Histone H3, AKT1, BIRC6, and XIAP were determined by western blotting as
described in Chapter II, Section C. 3.
Analysis of HDAC activity
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The nuclear protein was extracted from the control and treated hNCCs by
using the EpiQuik Nuclear Extraction Kit (Epigentek) according to the
manufacturer’s protocol. The HDAC activity was measured using an HDAC
fluorometric activity assay kit (Enzo), in which an established HDAC inhibitor TSA
was taken as a control. 10 µg of nuclear extract was incubated with or without
inhibitor for 1 hour at 37 ºC and then stoped by the addition of the developer for
further 10-15 min. The absorbance was read on fluorimeter at 360 nm excitation
and 460 nm emission wavelength.
HDAC2 siRNA transfection
For HDAC2 siRNA transfection, hNCCs were transfected with HDAC2
siRNA or scrambled control siRNA in a final concentration of 25 nM as described
in Chapter II, Section C. 7
Statistical analysis
Statistical analysis was performed as described in Chapter II, Section D.
C. Results
1. SFN diminished the ethanol-induced increase HDAC activity and the
up-regulation of HDAC2 in hNCCs.
To determine the effects of ethanol and SFN on HDAC activity, hNCCs were
pretreated with or without 1 μM SFN for 24 hours, followed by concurrent exposure
to 1 μM SFN or 50 mM ethanol for additional 24 hours. We found that exposure to
ethanol alone for 24 hours significantly increased the activity of HDAC in hNCCs.
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Co-treatment with SFN significantly reduced the ethanol-induced increase in the
activity of HDAC. In addition, ethanol exposure resulted in a significant increase in
the protein expression of HDAC2 in hNCCs. Treatment with SFN dramatically
reduced the up-regulation of HDAC2 in hNCCs exposed to ethanol (Figure 4.1A,
B). These results suggest that HDAC2 may contribute to the ethanol-induced
reduction of histone acetylation at the promoters of the anti-apoptotic genes in
hNCCs.
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Figure 4. 1. SFN treatment significantly decreased HDAC activity and HDAC2
expression in ethanol-exposed hNCCs. hNCCs were pre-treated with 1 µM SFN
for 24 hours and then co-treated with 1 µM SFN and 50 mM ethanol for an
additional 24 hours. (A) The nuclear protein was isolated from control and treated
hNCCs, and the HDAC activity was determined as described in methods. (B) The
protein expression of HDAC1, HDAC2, and HDAC3 in control and treated hNCCs
was determined by Western blot. Data are expressed as fold change over control
and represent the mean ± SEM of three separated experiments. *p<0.05.
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2. SFN diminished the ethanol-induced reduction of H3 acetylation at the
promoters of the selected anti-apoptotic genes in hNCCs.
To determine whether ethanol-induced increase in HDAC activity and upregulation of HDAC2 can result in the reduction of H3 acetylation at the promoters
of the selected anti-apoptotic genes and whether SFN that can inhibit HDAC
activity and diminish ethanol-induced up-regulation of HDAC2 can prevent
ethanol-induced reduction of H3 acetylation at the promoters of anti-apoptotic
genes, the expression of acetylated histone H3 was determined by western blot.
We found that ethanol exposure significantly decreased the levels of acetylated
histone H3 in hNCCs. Co-treatment with SFN diminished the reduction of
acetylated histone H3 in ethanol-exposed hNCCs. We then tested whether ethanol
exposure can decrease the acetyl-histone H3 binding to the promoters of the
identified anti-apoptotic genes in hNCCs by using ChIP-qPCR. Exposure to
ethanol significantly decreased the binding of acetylated histone H3 to the
promoters of AKT1, BIRC6 and XIAP. Co-treatment with SFN significantly
diminished ethanol-induced reduction of the binding of acetylated histone H3 to
the promoters of these anti-apoptotic genes in hNCCs (Figure 4.2B). These results
demonstrated that ethanol exposure can reduce the binding of acetylated histone
H3 to the promoters of the selected anti-apoptotic genes in hNCCs, which can be
prevented by SFN.
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Figure 4. 2. SFN increased acetyl-histone H3 protein levels and histone H3
acetylation at the promoters of AKT1, BIRC5, and XIAP in ethanol-exposed hNCCs.
hNCCs were pre-treated with 1 µM SFN for 24 hours and followed by 24 hours of
concurrent exposure of 1 µM SFN and 50 mM ethanol. (A) The acetyl-histone H3
protein expression was determined by using Western blot. (B) The schematic
depiction of the promoter regions of each gene and primer sets for chip experiment.
Acetyl-histone H3 enrichment at corresponding sites (P1-P3) was determined by
ChIP-qPCR. Data are expressed as fold change over control (A) or percentage of
input (B) and represent the mean ± SEM of three separated experiments. *p<0.05.
TSS: Transcriptional start site.
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3. SFN treatment diminished ethanol-induced down-regulation of AKT1,
BIRC6, and XIAP in ethanol-exposed hNCCs
To determine whether SFN-induced increase in acetylation at the
promoters of AKT1, BIRC6 and XIAP leads to the diminished down-regulation of
of these genes in ethanol-exposed hNCCs, the mRNA expression of AKT1, BIRC6
and XIAP was determined by using quantitative RT-PCR. The result has shown
that ethanol exposure significantly decreased the mRNA expression of AKT1,
BIRC6 and XIAP in hNCCs. SFN treatment significantly diminished the ethanolinduced down-regulation of these genes (Figure 4.3).
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Figure 4. 3. SFN treatment significantly increased the mRNA expression of
AKT1, BIRC6 and XIAP in ethanol-exposed hNCCs. hNCCs were pre-treated
with 1 µM SFN for 24 hours and then co-treated with 1 µM SFN and 50 mM
ethanol for an additional 24 hours. The mRNA expression of AKT1, BIRC6 and
XIAP was determined by quantitative RT-PCR. Data are expressed as fold
change over control and represent the mean ± SEM of three separated
experiments.

70

4. Knockdown of HDAC2 prevented ethanol-induced down-regulation of
AKT1, XIAP and BIRC6 in hNCCs.
To confirm that HDAC2 contributes to the ethanol-induced reduction of the
binding of acetylated histone H3 to the promoters of the selected anti-apoptotic
genes and subsequent down-regulation of these genes, HDAC2 was knocked
down by siRNA in hNCCs before treatment with ethanol and SFN. We found that
ethanol exposure resulted in a significant decrease in mRNA expression of AKT1,
BIRC6 and XIAP. Protein expression of AKT1, BIRC6 and XIAP was also
decreased in ethanol-exposed hNCCs. The knockdown of HDAC2 significantly
diminished ethanol-induced decreases in the mRNA and protein expression of
AKT1, BIRC6 and XIAP. The knockdown of HDAC2 also enhanced the effects of
SFN on the mRNA and protein expression of AKT1, BIRC6 and XIAP (Figure 4.4A,
B). These results demonstrate that knockdown of HADC2 can diminish ethanolinduced repression of anti-apoptotic genes in hNCCs.
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Figure 4. 4. Knockdown of HDAC2 prevented ethanol-induced down-regulation of
AKT1, XIAP and BIRC6 in hNCCs. hNCCs transfected with control-siRNA or
HDAC2-siRNA were treated with 1µM SFN or 50 mM ethanol or co-treated with
SFN and ethanol for 24 hours. (A) The mRNA expressions of AKT1, BIRC5, and
XIAP were determined by quantitative RT-PCR. (B) The protein level of AKT1,
BIRC5 and XIAP were determined by western blotting. Data are expressed as fold
change over control and represent the mean ± SEM of three separated
experiments. *p < 0.05, **p<0.01, ***p<0.001.
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5. The knockdown of HDAC2 and SFN treatment prevented ethanolinduced apoptosis in hNCCs.
To determine whether ethanol-induced up-regulation of HDAC2 and
subsequent reduction of the binding of acetylated histone H3 to the promoters of
the selected anti-apoptotic genes and repression of these genes contribute to
ethanol-induced apoptosis and whether SFN can prevent ethanol-induced
apoptosis by diminishing ethanol-induced up-regulation of HDAC2, HDAC2 was
knocked down by siRNA in hNCCs. We found that ethanol exposure significantly
increased apoptosis in hNCCs. The knockdown of HDAC2 by siRNA or downregulation of HDAC2 by SFN significantly diminished ethanol-induced apoptosis in
hNCCs (Figure 4.5). These results demonstrate that ethanol-induced up-regulation
of HDAC2 contributes to ethanol-induced apoptosis and that SFN can prevent
ethanol-induced apoptosis in hNCCs by diminishing ethanol-induced up-regulation
of HDAC2.
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Figure 4. 5. The knockdown of HDAC2 by siRNA or SFN treatment prevented
ethanol-induced apoptosis in hNCCs. hNCCs transfected with siRNA-HDAC2 or
siRNA-control were treated with 1 µM SFN or 50 mM ethanol or co-treated with
ethanol and SFN for an additional 24 hours, the protein expression of HDAC2 and
cleaved caspase-3 were determined by Western blotting. Data are expressed as
fold change over control and represent the mean ± SEM of three separated
experiments. *p < 0.05, **p<0.01.
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D. Discussion
A recent study has shown that SFN can epigenetically restore the expression
of Bcl2 and attenuating ethanol-induced apoptosis by enhancing the acetylation
levels on histone H3 at the promoter of Bcl218. The results from this study have
shown that treatment with SFN significantly decreased the enzymatic activity of
HDACs in ethanol-exposed hNCCs, which is consistent with the results from our
and other’s work18, 125, 175. I also found that ethanol exposure decreased the histone
H3 acetylation, suggesting that ethanol-induced inhibition of HDACs activity is
associated with a decrease in histone H3 acetylation levels. This result was
supported by the study that has shown that ethanol-induced increase in whole
hippocampus HDAC activity was related to a decrease in histone H3 acetylation
levels176. I also found that treatment with SFN significantly diminished the ethanolinduced decrease in histone H3 acetylation. In addition, ethanol exposure
significantly reduced the level of histone H3 acetylation at the promoters of AKT1,
BIRC6 and XIAP. Treatment with SFN prevented ethanol’s effect on the histone
H3 acetylation at the promoters of AKT1, BIRC6 and XIAP.
To further explore the molecular mechanisms underlying the changes of
histone H3 acetylation at the promoters of anti-apoptotic genes, I have analyzed
the protein levels of HDAC1, HDAC2 and HDAC3. These three HDACs belong to
the class I HDACs, which are expressed in all tissues and localized mainly in the
nucleus. It was reported that class I HDACs were associated with embryonic
lethality177 and that HDAC2 has been shown to be a crucial molecule to preserve
hippocampal memory and normal cognitive function 166. The study by Xiang B et
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al., has also demonstrated that HDAC2 was involved in regulating early brain
development178. Here, I found that ethanol exposure significantly increased
HDAC2 expression in hNCCs. This result is consistent with the in vivo study
showing that an increase in HDAC2 expression in aged male offspring after
maternal consumed ethanol during periconceptional period 179, as well as an in vitro
study demonstrating that ethanol treatment can increase HDAC2 expression in a
dose-dependent manner in the human neuronal cell line 180. Interestingly, the
HDAC inhibitor, trichostatin (TSA) can attenuate alcohol-drinking behaviors, with a
concomitant reduction in the expression of HDAC2 181. HDAC inhibitor also
significantly inhibited the ethanol-induced increase of HDAC2180. Consistent with
these findings, I have found that SFN, as an HDAC inhibitor, can decrease the
ethanol-induced increase in HDAC2 expression and HDAC activity in hNCCs.
Previous studies have shown that HDACs can modulate acetylation within
given gene promoters and regulate the transcription of the specific genes. For
example, HDAC inhibitor VPA upregulated the expression of anti-apoptotic gene
Hsp70 by enhancing the acetylation of histone H3 at Hsp70 promoter 68. In addition,
in ethanol-exposed adulthood rat, high HDAC activity and HDAC2 expression and
deficits in histone H3 acetylation at the promoters of brain-derived neurotrophic
factor (BDNF) and decreased expression of BDNF were observed, which were
reversed by knockdown of HDAC2 using TSA176. In the present study, I found that
knockdown of HDAC2 by transfected with siRNA-HDAC2 significantly increased
the expression of AKT1, XIAP and BIRC6 at both mRNA and protein levels, and it
can also enhance SFN’s effects on promoting the expression of AKT1, XIAP and
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BIRC6 in ethanol-exposed hNCCs. These results suggest that ethanol-induced upregulation of HDAC2 and an increase in HDAC activity contribute to ethanolinduced down-regulation of the anti-apoptotic genes in hNCCs.
Increasing evidence has shown that the downregulation of HDACs can
alleviate apoptosis in vitro and in vivo68, 182, 183. For example, Marisela et al., has
reported that HDAC2 inhibitor TSA exerted a neuroprotective effect through
reducing ethanol-induced excessive ROS180. Furthermore, inhibition of HDAC2 by
its inhibitor CAY10683 offers a protective effect on inhibiting apoptosis in mouse
model183. As an HDAC inhibitor, SFN can also inhibit LPS-induced apoptosis in
monocyte-derived dendritic cells, accompanied by a reduction of HDAC activity
and the expression of HDAC6 and HDAC10118. Additionally, our recent study has
shown that SFN can prevent ethanol-induced apoptosis through inhibiting HDAC
activity and increase the level of histone H3 acetylation at the promoter of Bcl218.
Consistent with these findings, I have found that knockdown of HDAC2 significantly
decreased caspase-3 activation in ethanol-exposed hNCCs and enhanced SFN’s
protective effects on ethanol-induced apoptosis in hNCCs, suggesting that SFN
can diminish hNCCs from ethanol-induced apoptosis by inhibiting HDAC2.
In summary, the present study indicated that treatment with SFN significantly
decreased the ethanol-induced increase in the enzymatic activity of HDACs and
inhibited ethanol-induced upregulation of HDAC2. Treatment with ethanol
significantly decreased acetylation of histone H3 at the promoter of AKT1, BIRC6
and XIAP, which can be prevented by co-treatment with SFN. Diminished
reduction of acetylation at the promoters of AKT1, BIRC6 and XIAP induced by
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SFN reduced ethanol-induced down-regulation of these genes in ethanol-exposed
hNCCs. Knockdown of HDAC2 also prevented the ethanol-induced downregulation of AKT1, BIRC6 and XIAP, and subsequently prevented apoptosis in
ethanol-exposed hNCCs. These findings demonstrate that SFN can diminish
ethanol-induced apoptosis in hNCCs by modulating HDAC2 and diminishing
histone acetylation at the promoters of the selected anti-apoptotic genes.
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CHAPTER V
SULFORPHANE PROTECTS AGAINST ETHANOL-INDUCED APOPTOSIS IN
NEURAL CREST CELLS AND ZEBRAFISH EMBRYOS THROUGH
MODULATING HISTONE METHYLATION AND THE EXPRESSION OF SNAIL1
AND RESTORING EMT
Introduction
Fetal Alcohol Spectrum Disorder (FASD) is a major developmental defect
caused by alcohol consumption by women during pregnancy. FASD is
characterized by craniofacial abnormalities, mental retardation and behavior
defect184-186. Studies have demonstrated that ethanol-induced excessive cell death
in the specific cell population is one of the major mechanisms underlying the
pathogenesis of FASD187, 188. Our studies and others have shown that ethanol can
induce apoptosis in neural crest cells (NCCs) and that ethanol-induced apoptosis
in NCCs contributes significantly to ethanol-induced malformations132, 155, 189.
NCC is a multipotent and migratory progenitor cell population that originates
between the neural plate and non-neural ectoderm10. After induction at the border
of the neural plate, NCCs leave their original location through a delamination
process and migrate ventrally to differentiate into a diversity of neural and nonneural cell types, including neuron, glia, craniofacial cartilage, bone and connect
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tissue91-93,

190

. NCC delamination process involves epithelial-to-mesenchyme

transition (EMT). EMT is a process that orchestrates a change from an epithelial
to a mesenchymal phenotype, a process that increases migratory properties,
invasiveness and apoptotic resistance95,

96

. EMT is essential for both normal

development and cancer invasion and metastasis97-99. During embryonic
development, NCCs undergo an EMT and then dissociate from the neural folds
and differentiate to a diversity of cell types10, 91, 93. EMT also plays a pivotal role in
promoting tumor proliferation, invasion, and metastasis, exerting an anti-apoptosis
effect100, 191. Studies have shown that EMT conferred resistance to UV-induced
apoptosis in three murine mammary epithelial cell lines102. Park et al. have also
shown that α-mangostin can inhibit EMT and induce apoptosis in an osteosarcoma
cell line103. However, the roles of EMT in ethanol-induced apoptosis in NCCs and
in the pathogenesis of FASD remain to be defined.
One of the well-known transcriptional factors that regulate EMT is Snail1104-106.
Snail1 promotes EMT primarily through the directly repressing E-cadherin, an EMT
suppressing factor104, 107, 192. The expression of Snail1 can be regulated by many
mechanisms, including epigenetic regulation. Epigenetic modification generally
includes DNA methylation and histone modification, which includes histone
acetylation and methylation48. Among the histone methylation, the triple methyl
modification on the fourth lysine of histone 3 (H3K4me3) typically facilitates the
activation of gene transcription72, while lysine demethylase 5A (KDM5A), the
member of KDM superfamily, has been shown to specifically catalyzing the
removal of tri-methyl from H3K4 and initiating the transcriptional repression
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process193-195. Previous studies have established that KDM5A can cooperate with
different transcriptional factors to selectively repress gene transcription 193, 195-197.
Given

the

intimate

association

between

H3K4

methylation

and

neurodevelopmental disorder, it is rational to assume that KDMs that are
responsible for demethylation of H3K4me associated with neurodevelopmental
disorder 194, 198, 199.
Sulforaphane (SFN) is a vegetable-derived isothiocyanate that is abundant in
cruciferous vegetables such as broccoli. Our previous studies have shown that
SFN exerts an anti-apoptotic effect through upregulating antioxidant gene Nrf-2 in
NCCs17. Our recent studies have also shown that SFN can prevent ethanolinduced apoptosis in NCCs by reversing ethanol-induced reduction of histone
acetylation at the promoter of the anti-apoptotic gene, Bcl218. More recently, SFN
had been reported to act as an inhibitor of histone deacetylase (HDAC) and DNA
methyltransferase (DNMT), two key enzymes involved in histone deacetylation
and DNA methylation, respectively, to cause epigenetic modification of genes in
varied types of cells, including the genes involved in EMT in cancer cells

115-117

.

Interestingly, studies have also shown that HDAC inhibitor also has a high
inhibitory effect on KDMs200 and that HDAC inhibitor decreased KDM5A
expression and modulated the expression of histone markers H3Ac and
H3K4me3201. However, the role of SFN and KDMs in the epigenetic regulation of
EMT transcriptional factors and ethanol-induced apoptosis in NCCs remains
unknown.
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In the present study, I tested the hypothesis that SFN can protect against
ethanol-induced apoptosis by restoring EMT through epigenetically modulating the
expression of Snail1 in NCCs. I found that treatment with SFN significantly
reversed ethanol-induced changes in the expression of E-cadherin, and restored
EMT in NCCs. I also found that ethanol exposure significantly reduced the levels
of H3K4me3 at the promoters of Snail1. SFN treatment reduced the ethanolinduced reduction of H3K4me3 at the promoter regions of the Snail1 gene and
restored Snail1 gene expression and EMT. In addition, I found that ethanol
exposure increased the expression of KDM5A, which was decreased by cotreatment with SFN. Knockdown KDM5A by siRNA prevented the ethanol-induced
decrease of H3K4me3 enrichment at Snail1 promoter, restored Snail1 gene
expression and subsequently restored EMT in NCCs exposed to ethanol. I have
also found siRNA mediated downregulation of KDM5A dramatically diminished
ethanol-induced apoptosis in NCCs as well as zebrafish embryos. These results
demonstrate that ethanol exposure can induce apoptosis in NCCs by inhibiting
EMT and that SFN can protect against ethanol-induced apoptosis by epigenetically
regulating the expression of Snail1 and restoring EMT.
Experimental procedures
Cell culture and treatment
NCCs (JoMa 1.3 cell) were cultured on culture dishes coated with
fibronectin. NCCs were treated with SFN and ethanol, as described in Chapter II,
Section A.
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Quantitative real-time PCR
The mRNA expression of Snail1, KDM5A, E-cadherin, Vimentin, and
Snail1 were measured by quantitative real-time RT-PCR as described in Chapter
II, Section C. 2.
Western blot analysis
The protein level of KDM5A, H3K4me3, H3, E-cadherin, Vimentin, Cleaved
caspase-3, and Snail1 were determined by western blotting as described in
Chapter II, Section C. 3.
Chip-qRT-PCR analysis
ChIP experiments were performed as described in Chapter II, C. 4.
Chromatin was immunoprecipitated with antibodies to H3K4me3. The qRT-PCR
was carried out with primers shown in Chapter II, C. 4.
TUNEL staining
Analysis of apoptosis in 24 hpf zebrafish embryos of control and
experimental groups was performed by using TUNEL staining as described in
Chapter II, B. 3.
Flow cytometry
Apoptosis in NCCs was determined by using Flow cytometry, as described
in Chapter II, C. 5.
siRNA Knockdown of KDM5A and Snail1
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For Snail1 or KDM5A siRNA transfection, NCCs were transfected with
Snail1 siRNA, KDM5A siRNA or scrambled control siRNA as described in Chapter
II, C. 7.
Statistical analysis
Statistical analysis was performed, as described in Chapter II, C. 8.
C. Results
1. Ethanol exposure induced apoptosis in NCCs
To determine whether ethanol exposure can induce apoptosis in NCCs,
NCCs were exposed to 50 or 100 mM ethanol, and ethanol-induced apoptosis was
determined by the analysis of caspase-3 activation and Annexin V staining. As
shown in Figure 5.1A, ethanol exposure resulted in significant increases in
caspase-3 activation in a dose-dependent manner, indicating that ethanol
treatment can induce apoptosis in NCCs. This result was confirmed by the results
from the flow cytometric analysis of Annexin V staining, which have shown that
exposure of NCCs to 50 or 100 mM ethanol caused a substantial increase in the
number of early apoptotic NCCs (Figure 5.1B)
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Figure 5. 1. Ethanol exposure induced apoptosis in NCCs. NCCs were exposed
to 50 or 100 mM ethanol for 24 h. Apoptosis was determined by the analysis of
caspase-3 cleavage by western blotting (A, B) or flow cytometry with Annexin VFITC apoptosis detection kit (B). Data are expressed as fold change over control
(A) or percentage of all cells (B) and represent the mean ± SEM of three separated
experiments. *p<0.05, **p<0.01.
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2. SFN diminished ethanol-induced inhibition of EMT in NCCs
To determine whether ethanol exposure can induce apoptosis in NCCs by
inhibiting EMT and whether SFN can protect NCCs against apoptosis through
restoring EMT, NCCs were cultured with 1 µM SFN alone for 24 hours, followed
by 24 hours of concurrent exposure to 1 µM SFN and 50 mM ethanol. As shown
in Figure 5. 2, ethanol treatment significantly inhibited EMT in NCCs, as indicated
by the increased expression of E-cadherin, an EMT-suppressing marker, and a
decreased expression of vimentin, an EMT-promoting marker. Treatment with SFN
significantly reversed ethanol-induced changes in the expression of E-cadherin
and vimentin and restored EMT in NCCs. These results indicate that ethanol
exposure can inhibit EMT in NCCs, which can be reversed by SFN.
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Figure 5. 2. SFN diminished ethanol-induced EMT inhibition in NCCs. NCCs were
pre-treated with 1 μM SFN for 24 h and followed by 24 h of concurrent exposure
to SFN and ethanol. The expression of EMT-suppressing factor E-cadherin and
EMT-promoting factor vimentin was determined by western blotting. Data are
expressed as fold change over control and represent the mean ± SEM of three
separated experiments. *p < 0.05, **p<0.01.
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3. SFN diminished the ethanol-induced increases in the mRNA and
protein expression of KDM5A in NCCs.
KDM5A, a histone demethylase, has been shown to directly remove trilysine of histone H3193, 194, 202. To determine whether KDM5A is involved in the
ethanol-induced alteration in histone methylation, the expression of KDM5A was
determined in control and ethanol-exposed NCCs. As shown in Figure 5.3A, B,
qRT-PCR and Western blot analysis revealed a significant increase in the mRNA
and protein expression of KDM5A in ethanol-exposed NCCs. Co-treatment with
SFN and ethanol diminished the ethanol-induced up-regulation of KDM5A in NCCs.
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Figure 5. 3. SFN diminished ethanol-induced increases in the mRNA and protein
expression of KDM5A in NCCs. NCCs were pretreated with 1 µM SFN for 24 h and
followed by 24 h of concurrent exposure to SFN and 50 mM ethanol for 24 h. (A)
The mRNA expression of KDM5A was determined by quantitative RT-PCR. (B)
Protein expression of KDM5A was determined by western blotting. Data are
expressed as fold change over control and represent the mean ± SEM of three
separated experiments. *p<0.05, **p<0.01.
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4. SFN treatment diminished the ethanol-induced reduction in the
H3K4me3 enrichment at the promoter regions of the Snail1 gene in
NCCs.
Snail1 is a key transcriptional repressor of E-cadherin and plays an
important role in the regulation of EMT104, 107, 192. To determine the mechanisms by
which ethanol inhibits EMT and SFN diminishes the ethanol-induced inhibition of
EMT in NCCs, I next determined whether ethanol and SFN can modulate EMT
through epigenetically regulating the expression of Snail1. I first determined
whether ethanol exposure can reduce the H3K4 trimethylation (H3K4me3), an
epigenetic modification that is associated with the activation of transcription of
genes72, 203. As shown in Figure 5.4A, exposure to 50 mM ethanol resulted in a
significant decrease in the levels of H3K4me3 in NCCs. Co-treatment with SFN
and ethanol significantly increased the H3K4me3 expression in NCCs, indicating
that ethanol-induced reduction of H3K4 trimethylation in NCCs can be diminished
by SFN. In addition, the ChIP-qPCR analysis revealed that ethanol exposure
resulted in a significant reduction of H3K4me3 enrichment at the promoter regions
of Snail1. SFN can diminish the ethanol-induced reduction of H3K4me3
enrichment at the promoter regions of Snail1 (Figure 5.4C).
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Figure 5. 4. SFN diminished the ethanol-induced reduction of the levels of
H3K4me3 at the Snail 1 promoter. (A) The levels of H3K4me3 in control and
treated NCCs were determined by western blot. (B) Schematic depiction of the
Snail1 promoter and the primer sets for ChIP-qPCR analyses. (C) H3K4me3
enrichment at corresponding sites (P1-P5) was determined by ChIP-qPCR. Data
are expressed as fold change over control (A) or the percentage of input (C) and
represent the mean ± SEM of three separated experiments *p < 0.05. TSS:
Transcriptional start site.
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5. SFN treatment restored the expression of Snail1 in ethanol-exposed
NCCs
I next tested whether the ethanol-induced reduction of H3K4me3
enrichment at the promoter regions of Snail1 can downregulate the Snail1 and
whether SFN treatment can restore the expression of Snai1 in ethanol-exposed
NCCs. As expected, qRT-PCR and Western blot analysis revealed a significant
decrease in the mRNA and protein expression of Snail1 in ethanol-exposed NCCs.
Treatment with SFN restored the mRNA and protein expression of Snail1 in NCCs
exposed to ethanol (Figure 5.5). This result demonstrates that SFN can prevent
ethanol-induced down-regulation of Snail1 in NCCs.
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Figure 5. 5. SFN restored Snail1 expression in ethanol-exposed NCCs. NCCs
were exposed to 1 µM SFN for 24 h, followed by concurrent exposure to 1 µM SFN
and 50 mM ethanol for 24 h. The expression of Snail1 mRNA (A) and protein (B)
was determined by quantitative RT-qPCR and Western blot, respectively. Data are
expressed as fold change over control and represent the mean ± SEM of three
separated experiments. *p<0.05, **p<0.01.
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6. Treatment with SFN significantly decreased the up-regulation of
Snail1 target gene E-cadherin in NCCs exposed to ethanol
To determine whether ethanol-induced down-regulation of Snail1 can
increase the expression of E-cadherin, a Snail1 target gene and an EMT
suppressing marker, in NCCs and whether SFN can diminish ethanol-induced upregulation of E-cadherin, the mRNA expression of E-cadherin was determined in
control and treated NCCs. As shown in Figure 5.6, exposure of NCCs to ethanol
resulted in a significant increase in E-cadherin expression. Treatment with SFN
significantly diminished ethanol-induced up-regulation of E-cadherin in NCCs.
Since the down-regulation of E-cadherin is considered to be a hallmark of EMT 106,
204

, these results demonstrate that SFN can prevent ethanol-induced inhibition of

EMT in NCCs.
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Figure 5. 6. SFN diminished the expression of Snail1 target gene E-cadherin in
ethanol-exposed NCCs. NCCs were pre-treated with 1 μM SFN for 24 h and then
exposed to 1 μM SFN and 50 mM ethanol for an additional 24 h. The expression
of E-cadherin mRNA was determined by quantitative RT-PCR. Data are expressed
as fold change over control and represent the mean ± SEM of three separated
experiments. *p < 0.05.
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7. SFN treatment significantly diminished ethanol-induced apoptosis in
NCCs through up-regulation of Snail1
To determine whether SFN can prevent ethanol-induced apoptosis,
caspase-3 activation and Annexin V staining were examined in control and treated
NCCs. As shown in Figure 5.7A, exposure of NCCs to ethanol resulted in a
significant increase in caspase-3 activation, indicating that ethanol exposure
induced apoptosis in NCCs. Treatment with SFN significantly reduced caspase-3
activation in NCCs exposed to ethanol. To further confirm that SFN can diminish
ethanol-induced apoptosis through up-regulation of Snail1, apoptosis was
analyzed by the flow cytometric analysis of Annexin V staining in NCCs transfected
with control or Snail1 siRNA. I found that knockdown of Snail1 by siRNA
significantly increased ethanol-induced apoptosis as compared to the NCCs
transfected with control siRNA, confirming that down-regulation of Snail1 can
induce apoptosis in NCCs. Down-regulation of Snail1 by siRNA also significantly
diminished the protective effects of SFN on ethanol-induced apoptosis in NCCs
(Figure 5.7B), indicating that SFN can attenuate ethanol-induced apoptosis by
modulating the expression of Snail1, further supporting our hypothesis.
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Figure 5. 7. SFN diminished ethanol-induced apoptosis in NCCs through the upregulation of Snail1. (A) NCCs were exposed to 1 µM SFN for 24 h, followed by
concurrent exposure to 1 µM SFN and 50 mM ethanol for 24 h. Apoptosis was
determined by the analysis of caspase-3 cleavage using Western blot (B) NCCs
transfected with control or Snail1 siRNA was determined by Western blot.
Apoptosis was determined by flow cytometry with Annexin V-FITC apoptosis
detection kit. Data are expressed as fold change over control (A) or percentage of
all cells (B) and represent the mean ± SEM of three separated experiments.
*p<0.05, **p<0.01.
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8. The knockdown of KDM5A significantly diminished the ethanolinduced inhibition of H3K4me3 expression and reduction of H3K4me3
enrichment at Snail1 promoters.
To further explore the effect of KDM5A on the ethanol-induced reduction of
H3K4me3 enrichment at Snail1 promoter, the expression of H3K4me3 and the
H3K4me3 enrichment at Snail1 promoter in NCCs transfected with control or
KDM5A siRNA were analyzed. The results indicated that knockdown of KDM5A by
siRNA significantly reduced the ethanol-induced inhibition of H3K4me3 expression
in NCCs (Figure 5.9A). In addition, the ChIP-qPCR analysis revealed that NCCs
transfected with siKDM5A significantly diminished ethanol-induced reduction of
H3K4me3 at Snail1 promoter regions (Figure 5.9B).
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Figure 5. 8. Down-regulation of KDM5A significantly diminished ethanol-induced
inhibition of H3K4me3 expression and reduction of H3K4me3 enrichment at the
Snail1 promoter regions in NCCs. NCCs transfected with control siRNA, or
KDM5A-siRNA were treated with or without 50 mM ethanol for 24 hours. (A). The
nuclear protein was extracted and the expression of H3K4me3 and histone H3
were determined by western blotting. The KDM5A expression at the protein level
was determined by western blotting. (B). H3K4me3 enrichment at corresponding
sites (P1-P5) was determined by ChIP-qPCR. Data as fold change over control (A)
of percentage of input (B) and represent the mean ± SEM of three separated
experiments. *p < 0.05, **p< 0.01.
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9. Down-regulation of KDM5A diminished ethanol-induced inhibition of
EMT in NCCs.
To determine whether ethanol-induced up-regulation of KDM5A contributes
to ethanol-induced inhibition of EMT, the effects of down-regulation of KDM5A on
the expression of Snail1 were determined in ethanol-exposed NCCs. As expected,
knockdown of KDM5A prevented the ethanol-induced down-regulation of Snail1
(Figure 5.9A). Snail1 is a key transcriptional factor that promotes EMT by targeting
EMT repressing maker E-cadherin96,

104, 106, 107

. I further determine the mRNA

expression of E-cadherin in NCCs transfected with control or KDM5A siRNA. As
observed in Figure 5.9B, NCCs transfected with siKDM5A significantly reduced
ethanol-induced increase of E-cadherin expression. To further determine whether
the downregulation of KDM5A can restore ethanol-induced inhibition of EMT in
NCCs, both EMT promoting marker E-cadherin and repressing marker vimentin
were analyzed in NCCs transfected with control or KDM5A siRNA. As shown in
Figure 5.9C, ethanol treatment significantly inhibits EMT in NCCs, as indicated by
the increased protein expression of E-cadherin and a decreased protein
expression vimentin. Downregulation of KDM5A significantly reduced ethanolinduced changes in the expression of E-cadherin and vimentin. These results
clearly demonstrated that knockdown of KDM5A significantly prevented ethanolinduced inhibition of EMT in NCCs.
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Figure 5. 9. Down-regulation of KDM5A diminished ethanol-induced inhibition of
EMT in NCCs. NCCs transfected with control-siRNA or KDM5A-siRNA were
treated with or without 50 mM ethanol for 24 hours. The mRNA expression of
Snail1 (A) and E-cadherin (B) were determined by quantitative RT-qPCR. The
protein expression of E-cadherin and vimentin were determined by western blotting
(C). Data are expressed as fold change over control and represent the mean ±
SEM of three separated experiments. *p < 0.05, **p< 0.01.
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10. The knockdown of KDM5A significantly decreased ethanol-induced
apoptosis in NCCs and zebrafish embryos.
To determine whether the downregulation of KDM5A can prevent ethanolinduced apoptosis, apoptosis was analyzed by caspase-3 activation and Annexin
V staining in control and ethanol-exposed NCCs transfected with control or KDM5A
siRNA. As shown in Figure 5.10A, exposure of NCCs to ethanol resulted in a
significant increase in caspase-3 activation, knockdown of KDM5A by siRNA
significantly decreased caspase-3 activation in NCCs exposed to ethanol. The flow
cytometry results indicated that the number of apoptotic cells was dramatically
decreased in KDM5A deficient NCCs exposed to ethanol, as compared with the
ethanol-treated group (Figure 5.10B). To determine whether knockdown of
KDM5A prevented ethanol-induced apoptosis in vivo, zebrafish embryos were
microinjected with control or KDM5A morpholino at one cell-stage, and treated with
or without ethanol for 24 hours. TUNEL staining was used to determine the
apoptotic cells in the whole zebrafish embryos. As shown in Figure 5.10C, ethanol
treatment resulted in excessive apoptotic cells in the forebrain, middle brain and
hindbrain. Knockdown of KDM5A by microinjection with KDM5A morpholino
attenuate ethanol-induced apoptosis in zebrafish embryos.
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Figure 5. 10. The knockdown of KDM5A significantly decreased ethanol-induced
apoptosis in NCCs and zebrafish embryos. NCCs transfected with control, or
KDM5A siRNA were treated with or without 50 mM ethanol for 24 hours. Apoptosis
was determined by the analysis of caspase-3 cleavage by western blotting (A) or
flow cytometry with Annexin V-FITC apoptosis detection kit (B). Zebrafish embryos
were microinjected with control or KDM5A morpholino at the one-cell stage and
treated with or without for 24 hours. Apoptosis was analyzed by whole-mount
TUNEL staining of the zebrafish embryos from control and treated groups. Scale
bar: 200 µm. Data are expressed as fold change over control (A) and percentage
of whole cells (B) and represent the mean ± SEM of three separated experiments.
*p<0.05, **p<0.01.
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D. Discussion
Apoptosis in NCCs is one of the major mechanisms underlying the
pathogenesis of FASD. Recent studies have shown that SFN can epigenetically
restore the expression of Bcl-2 and attenuate ethanol-induced apoptosis by
enhancing histone acetylation at the Bcl-2 promoter18. The results from this study
have shown that treatment with SFN significantly prevented ethanol-induced
changes in the expression of E-cadherin and vimentin, and restored EMT in NCCs.
I also found that ethanol exposure significantly reduced the levels of H3K4me3 at
the promoter regions of Snail1. In addition, SFN treatment diminished the ethanolinduced reduction of H3K4me3 at the promoter regions of the Snail1 gene,
restored Snail1 gene expression and EMT. I have also found that the expression
of KDM5A was increased by ethanol, which can be diminished by SFN treatment.
Downregulation of KDM5A by siRNA significantly reduced ed ethanol-induced
inhibition of H3K4me3 expression as well as the H3K4me3 enrichment at the
promoter regions of the Snail1 gene. In addition, the Snail1 expression and EMT
were restored in KDM5A deficient NCCs exposed to ethanol. Moreover,
knockdown of KDM5A prevented ethanol-induced apoptosis in NCCs and
zebrafish embryos.
It is well known that the EMT is a process that can inhibit apoptosis, promote
the proliferation, migration and metastasis of tumor cells100, 191, 205, 206. Study has
shown that EMT conferred resistance to UV-induced apoptosis in murine
mammary epithelial cell lines102. It has also been shown that α-mangostin can
inhibit EMT and induce apoptosis in an osteosarcoma cell line. EMT is also critical
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for the development of tissues and organs in the embryos 93, 95, 97, and plays a
crucial role in the regulation of the migration of NCCs10,

91, 207

. However, the

involvement of EMT in the ethanol-induced apoptosis in NCCs is currently unclear.
I have demonstrated that ethanol treatment significantly inhibited EMT in NCCs,
as indicated by an increased expression of E-cadherin and a decreased
expression of vimentin, and induced apoptosis in NCCs. Treatment with SFN
significantly diminished ed ethanol-induced changes in the expression of Ecadherin and vimentin, restored EMT, and reduced apoptosis in NCCs. These
results suggest that inhibition of EMT contributes to ethanol-induced apoptosis in
NCCs.
Snail1 is a member of the Snail superfamily of zinc-finger transcription factors
that are involved in cell survival and differentiation 104, 105, 208. Snail1 has a crucial
role in the regulation of EMT through its repression of E-cadherin, an adhesion
molecule mostly expressed in the surface of epithelial-like cells51, 98, 192, 208, 209.
Studies have shown that ethanol treatment decreased the expression of Snail1
mRNA and inhibited EMT in B16-BL6 melanoma cells210 and that Snail1 repressed
TGF- β-induced apoptosis in hepatocytes by triggering EMT 205. Ethanol exposure
was also found to be able to down-regulate the Snail2 in NCCs of chick embryos
211

. Consistent with these findings, I found that ethanol exposure resulted in a

significant reduction in the expression of Snail1, accompanied by a dramatic
increase in the expression of E-cadherin in NCCs. These results suggest that
ethanol exposure can inhibit EMT in NCCs by down-regulating Snail1, leading to
the up-regulation of E-cadherin.
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The expression of Snail1 can be regulated by a variety of mechanisms.
Studies have shown that NF-kB, HIF-1a, SMAD, STAT3, and Gli1 can directly
interact with the Snail1 promoter and regulate Snail1 at the transcriptional level 192,
206, 208

. The expression of Snail1 can also be regulated epigenetically. In eukaryotic

cells, epigenetic regulation of gene expression mainly comprises DNA modification
and histone modification51, 72, 209. It has been reported that HDAC inhibitor valproic
acid (VPA) elevated histone acetylation to transcriptionally activate Snail1 gene
expression and promote EMT in colorectal cancer cells 108. HDAC inhibitors,
Trichostatin A (TSA) and Suberoylanilide hydroxamic acid (SAHA) also induced
EMT in prostate cancer cells212. While acetylation of histone lysine residues can
increase genome accessibility, thus promoting gene transcription, methylation at
lysine residues can have either activating or repressing effects on gene
transcription. It is well-known that trimethylation of histone 3 at lysine 27
(H3K27me3) is associated with transcription repression while trimethylation of
histone 3 at lysine 4 (H3K4me3) is associated with transcription activation 213.
H3K4me3 is highly enriched at active promoters near transcription start sites and
is widely used as a histone mark to identify active gene promoters 214. Interestingly,
methylation of H3K4 is a kind of modifications that is associated with gene
activation, implicated in neurodevelopment disorder 194, 198, 199. In this study, I found
that ethanol exposure resulted in a significant decrease in the levels of H3K4me3
in NCCs and a significant reduction of H3K4me3 enrichment at the promoter
regions of Snail1. Co-treatment with SFN and ethanol significantly increased the
H3K4me3 expression in NCCs and diminished the ethanol-induced reduction of
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H3K4me3 enrichment at the promoter regions of Snail1. These results indicate that
the ethanol can induce apoptosis in NCCs by inhibiting EMT through epigenetically
down-regulating the expression of Snail1 which can be prevented by SFN.
One of the key histone demethylases that remove the activating mark of
H3K4me3 is KDM5A. KDM5A, also known as retinoblastoma binding protein 2
(RBP2), was associated with various cancer 215-217 and neurodevelopment
disorder198, 199. It has been shown that various HDAC inhibitors manifested a high
inhibitory activity for KDMs200. Consistent with this finding, I found that SFN, an
HDAC inhibitor, significantly decrease KDM5A in ethanol-exposed hNCCs.
Furthermore, substantial studies have established that KDM5A can repress gene
expression through maintaining the low levels of H3K4me3 at gene promoter 80, 218220

. The present study indicated that ethanol-induced overexpression of KDM5A

subsequently downregulated the H3K4me3 expression. In addition, knockdown of
KDM5A by siRNA significantly increased H3K4me3 expression in ethanol-exposed
NCCs. These results indicate that H3K4me3 is the direct target of KDM5A in NCCs.
In addition, the down-regulation of KDM5A by siRNA significantly reduced ethanolinduced reduction of H3K4me3 enrichment at Snail1 promoter and subsequently
restored Snail1 expression in NCCs. Furthermore, Snail1 is well recognized as a
direct repressor of E-cadherin and can promote EMT process96, 104, 106, 107. In the
present study, I found that the down-regulation of KDM5A by siRNA diminished
ethanol-induced increase in the expression of E-cadherin. These results indicated
that the up-regulation of KDM5A represses the expression of Snail1 through the
demethylation of H3K4me3 at Snail1 promoter, contributing to the inhibition of EMT
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in ethanol-exposed NCCs. The down-regulation of KDM5A by siRNA also
significantly protected the NCCs from ethanol-induced apoptosis. Additionally,
knockdown of KDM5A by microinjecting with morpholino KDM5A dramatically
decreased ethanol-induced apoptotic cell death in the craniofacial position of
zebrafish embryos. These results are consistent with the Klose’s work that show
that RBP2 (KDM5A) knockout mice displayed decreased apoptosis in
hematopoietic stem cells80.
In summary, the present study indicated that ethanol exposure can inhibit EMT
through the down-regulation of Snail1 by decreasing H3K4me3 enrichment at the
promoter regions of Snail1 and increase apoptosis in NCCs. SFN treatment can
diminish the ethanol-induced reduction in the H3K4me3 enrichment at the
promoter regions of Snail1, restore mRNA expression of Snail1 and EMT in NCCs
exposed to ethanol. Ethanol exposure also significantly up-regulated KDM5A,
which can be diminished by co-treatment with SFN. Furthermore, knockdown
KDM5A by siRNA increased the expression of H3K4me3 and H3K4me3
enrichment at the Snail1 promoter. Down-regulation of KDM5A also restored
Snail1 expression and EMT process and prevented apoptosis in ethanol-exposed
NCCs. These results demonstrate that the disruption of EMT contributes to
ethanol-induced apoptosis in NCCs and that SFN can prevent ethanol-induced
apoptosis by restoring EMT through epigenetically regulating the expression of
EMT-related genes, suggesting that elucidation of Snail1’s role in EMT and
ethanol-induced apoptosis in NCCs may provide critical insight into the
pathogenesis of FASD.
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CHAPTER VI
MATERNAL DIETARY ADMINISTRATION OF BROCCOLI SPROUT EXTRACT
DIMINISHED ETHANOL-INDUCED APOPTOSIS AND TERATOGENESIS IN
MOUSE EMBRYOS BY EPIGENETICALLY MODULATING ANTI-APOPTOTIC
GENES
Introduction
The previous work utilizing animal models has shown that exposure to ethanol
during the early stage of embryogenesis can result in craniofacial abnormalities
that are characteristic of fetal alcohol syndrome disorder (FASD). Specifically,
ethanol exposure could induce small head circumference, flat midface, short nose,
indistinct philtrum, thin upper lip, short palpebral fissures and other defects 221, 222.
Studies by Kotch and Sulik, as well as Dunty et al. in mice and Cartwright and
Smith in chicks have revealed the sensitivity of the craniofacial region and
developing brain to the deleterious effects of ethanol. These studies have shown
that ethanol exposure during gastrulation and/or neurulation resulted in excessive
apoptosis in neuroepithelium as well as other cell populations, including neural
crest cells and ectodermal placodes14, 130, 131, 156. The results of a whole embryo
culture study by Van Maele-Fabry et al. also support the conclusion that neural
crest cells and placodes are targets of ethanol’s teratogenesis 223.
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Furthermore, study by Debelak and Su et al. has shown that the severity of
ethanol-induced neural crest apoptosis and craniofacial dysmorphology is
influenced by genetics in an avian model of FASD224, 225. Taken together, ethanolinduced apoptosis contributes to the dysmorphology of the craniofacial region and
the developing brain in the FASD model. Therefore, preventing ethanol-induced
apoptosis could be a promising therapeutic strategy for the prevention of FASD.
Studies from our laboratory and others have shown that multiple signaling
pathways are involved in ethanol-induced apoptosis, including Sonic Hedgehog
(SHH) signaling226, p53 pathways227, epithelial-mesenchymal transition (EMT)133
and Bcl2 family228. For instance, SHH is a potent cell survival factor and disruption
in SHH signaling by ethanol may cause massive apoptosis in neural crest cells
and neuroepithelial cells226, 229, 230. Studies have also shown that ethanol exposure
caused oxidative stress, eventually triggering the apoptotic pathway 17, 231, 232. The
recent study from our laboratory has demonstrated that ethanol exposure
significantly decreased the expression of Snail1, one of the major EMT
transcriptional factors, and increased apoptosis in neural crest cells133. We have
also

shown

that

ethanol can

induce apoptosis through

epigenetically

downregulating the anti-apoptotic gene, Bcl2, and subsequently lead to massive
apoptosis in mouse embryos18. These results demonstrate that anti-apoptotic
genes are crucial in regulating apoptosis and ethanol’s teratogenesis. The
previous study in our laboratory indicated that sulforaphane (SFN), found
abundantly in broccoli and cruciferous vegetables, can reduce ethanol-induced
apoptosis in both neural crest cells and mouse embryos 17, 18, 133. More interestingly,
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studies have shown that SFN can epigenetically regulate apoptosis by acting as
an inhibitor of histone deacetylase (HDAC) and DNA methyltransferase (DNMT),
two key enzymes involved in histone deacetylation and DNA methylation 18, 133.
Recently, broccoli sprout extract (BSE), has gained a lot of attention because it
can specifically deliver a reproducible and standardized dose of glucoraphanin, a
precursor of SFN. Glucoraphanin is available in commonly consumed cruciferous
vegetables. BSE is considered to have low toxicity, and its administration in
humans is well tolerated120-122. It was reported that dietary consumption of BSE
can reduce the risk of several types of cancers, including prostate breast, lung and
colorectal cancers119, 123, 124. For instance, consumption of BSE inhibits HDAC
activity in peripheral blood mononuclear cells, accompanied by the induction of
acetylation of histone H3 and H4 in human subjects 125. Moreover, evidence by
Hashimoto et al. has shown that dietary intake of SFN-rich BSE was capable of
preventing PCP-induced cognitive deficits and oxidative stress in mice 126.
Furthermore, SFN-rich BSE significantly improves social interaction, abnormal
behavior and verbal communication in young men with autism spectrum
disorders120.
For the present investigation, I tested the hypothesis that maternal dietary
administration of BSE can prevent ethanol-induced apoptosis and teratogenesis
through epigenetically regulating the anti-apoptotic genes. Through using the in
vivo oral take FASD model system, I found that the anti-apoptotic genes were
hypermethylated by maternal consumption of ethanol, which can be diminished by
maternal dietary administration of BSE. Subsequently, maternal dietary BSE
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diminished ethanol-induced down-regulation of the anti-apoptotic genes. Moreover,
BSE consumption prevented ethanol-induced apoptosis in mouse embryos.
Furthermore, I found that maternal consumption of BSE conferred in vivo
protection against ethanol-induced teratogenesis, including the anterior tube
defects and ocular abnormalities in mouse embryos. These results demonstrate
that epigenetic modulation of the anti-apoptotic genes by maternal dietary SFNrich BSE represents a novel therapeutic strategy for the prevention of ethanolinduced teratogenesis.
Experimental Procedures
1. Animals and treatments
Animals were maintenance, treated with ethanol and BSE, as described in
Chapter II Section B.1 and in the Experimental scheme 6.1.
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Experimental scheme 6. 1. FASD mouse model and experimental procedure. Mice
received ethanol-containing or control liquid diet for an initial 14 days then moved
to the lab chow for mating. 4.8% ethanol liquid diet with or without 3 mg BSE/mL
diet was re-introduced to the experimental groups of pregnant mice on GD 7.0 and
GD 8.0. Pregnant mice will be killed on GD 9.0 or GD 14.0 for further analysis (see
Experimental procedure).
2. Methylated specific PCR (MSP)
Pregnant mice were sacrificed on GD 9 and the whole brain was dissected
from the mouse embryos from control and experimental groups. The genome DNA
was isolated from the whole brain of embryos from control and experimental
groups, and DNA methylation at the promoters of the anti-apoptotic genes was
determined as described in Chapter II, C. 6.
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3. Dysmorphology assessment
Pregnant mice were sacrificed on GD 9, and the embryos were dissected
and kept in ice-cold PBS. The embryos were then photographed under a
microscope (SZX16, Olympus, USA). Ocular dysmorphology was assessed at GD
14. The pregnant mice were sacrificed on GD 14, and the embryos were dissected
from the uterus. The eyes were photographed under a microscope (SZX16,
Olympus, USA).
4. TUNEL Staining
Analysis of apoptosis in mouse embryos was performed by using a TMR
Red in Situ Detection Kit (Millipore, Temecula, CA), following the manufacturer’s
protocol. Briefly, the mouse embryos were fixed with 4% paraformaldehyde
overnight, then dehydrated in 100% methanol at -20 ºC for at least 2 hours,
following by rehydrating the embryos through a series of methanol dilutions. Then
the embryos were permeabilized with proteinase K at room temperature for 8 min
following with 0.1% Triton-100 in 0.1% sodium citrate treatment at room
temperature for an additional 15 min. After that, the embryos were pre-fixed with
4% paraformaldehyde for 20 min and then stained with the TUNEL reaction
mixture at 37 ºC for 1 hour. Following the staining, the mouse embryos were
visualized in the green channel of a fluorescent microscope (SZX16, Olympus,
USA).
5. Quantitative real-time PCR
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mRNA expression of AKT1, BIRC5, BCl2, and NAIP were determined by
quantitative real-time PCR, as described in Chapter II, Section C.2.
6. Western Blot
The protein level of AKT1, BIRC5, BCl2, NAIP, and Cleaved caspase-3,
were determined by western blot, as described in Chapter II, Section C.3.
7. Statistical analysis
Statistical analysis was performed, as described in Chapter II, C. 8.
C. Results
Maternal dietary BSE administration significantly reduced ethanolinduced hypermethylation at the promoters of the selected antiapoptotic genes in mouse embryos.
To determine whether maternal dietary BSE can reduce ethanol-induced
hypermethylation at the promoter regions of the anti-apoptotic genes in mouse
embryos exposed to ethanol, the whole brain was dissected from GD 9.0 mouse
embryos, and the methylation levels at the promoter regions of the anti-apoptotic
genes were analyzed. As shown in Figure 6.1, maternal dietary BSE significantly
diminished ethanol-induced hypermethylation at the promoters of AKT1, Bcl2 and
NAIP in mouse embryos.
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Figure 6. 1. Maternal dietary BSE significantly diminished ethanol-induced

hypermethylation at the promoters of AKT1, Bcl2 and NAIP in mouse embryos.
Control and treated mice were sacrificed at GD 9.0. The whole brain was dissected
from the embryos and the genome was isolated. (A) Schematic illustration of CpG
sites and CpG island at the promoters of the anti-apoptotic genes. (B) DNA
methylation status at the CpG island of the selected anti-apoptotic genes was
determined by using MSP. Data are expressed fold change over control and
represent the mean ± SEM of three separated experiments. *p < 0.05, **p< 0.01,
***p<0.001.
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Maternal dietary BSE reduced the ethanol-induced down-regulation of
the selected anti-apoptotic genes in mouse embryos
DNA methylation is the most extensively studied epigenetic modification,
which has an important role in the regulation of gene expression. DNA
hypermethylation on CpG island compacts the chromatin, silencing the gene
expression. Conversely, when DNA methylation is lowered, the chromatin is
allowed to open and subsequently leads to gene activation 233, 234. To determine
whether the diminished hypermethylation at the promoter region of the antiapoptotic genes induced by maternal dietary BSE in ethanol-exposed mouse
embryos can reduce ethanol-induced down-regulation of the selected antiapoptotic genes, the expression of the anti-apoptotic genes was determined by
qRT-PCR and western blot. As expected, ethanol treatment alone robustly
decreased the mRNA expression of AKT1, Bcl2 and NAIP. BSE administration
significantly diminished the ethanol-induced down-regulation of these antiapoptotic genes (Figure 6.2A). Moreover, maternal dietary BSE also significantly
diminished ethanol-induced decrease in the protein expression of AKT1, Bcl2 and
NAIP in mouse embryos (Figure 6.2B). These results demonstrate that maternal
dietary BSE can prevent ethanol-induced down-regulation of the anti-apoptotic
genes.
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Figure 6. 2. Maternal dietary BSE prevented ethanol-induced down-regulation of
anti-apoptotic genes in mouse embryos. The control and treated mice were
sacrificed at GD 9.0, and then the whole brain was dissected from the mouse
embryos. The mRNA (A) and protein (B) expression of the anti-apoptotic genes
were analyzed by quantitative RT-PCR and Western blot, respectively. Data are
expressed as fold change over control and represent the mean ± SEM of three
separated experiments. *p < 0.05, **p< 0.01, ***p<0.001.
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Maternal dietary BSE protected against ethanol-induced apoptosis in
mouse embryos
To determine whether maternal dietary BSE can prevent ethanol-induced
apoptosis, apoptosis was examined by analysis of caspase-3 activation and wholemount TENEL staining in control and treated mouse embryos. As shown in Figure
6.3A, ethanol exposure resulted in a significant increase in caspase-3 activation,
indicating that ethanol exposure increased apoptosis in mouse embryos. BSE
administration significantly reduced caspase-3 activation in mouse embryos
exposed to ethanol. Moreover, the apoptotic cells were evaluated by whole-mount
TUNEL staining of control and treated GD 9.0 mouse embryos. As compared to
control group, ethanol-exposed mouse embryos displayed excessive apoptosis in
the hindbrain with staining most intensely in the hindbrain alar plate, additional
locations of excessive apoptosis were observed in the forebrain, middle brain
(white arrow), trigeminal ganglion (V) as well as first arch (I). BSE administration
significantly attenuated ethanol-induced excessive apoptosis in mouse embryos
(Figure 6.3B). These results demonstrate that maternal dietary BSE can prevent
ethanol-induced apoptosis in mouse embryos.
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Figure 6. 3. Maternal dietary BSE protects against ethanol-induced apoptosis in
mouse embryos. The control and treated mice were sacrificed at GD 9.0, and the
mouse embryos were dissected. (A) Apoptosis was determined by the analysis of
caspase-3 cleavage using Western blot. (B) The whole-mount TUNEL staining of
mouse embryos from control and treated groups was visualized under a
fluorescence microscope. Data are expressed as fold change over control and
represent the mean ± SEM of three separated experiments. **p< 0.01 ***p<0.001.
I=first arch; V=trigeminal ganglion.
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Maternal dietary BSE confers in vivo protection against ethanolinduced teratogenesis in mouse embryos.
To determine whether dietary consumption of BSE can prevent ethanolinduced teratogenesis, the morphology of the control and treated mouse embryos
was assessed on GD 9.0. As compared with control groups, ethanol-exposed
mouse embryos displayed a marked decrease in the size of the forebrain, midbrain
and hindbrain, BSE administration reduced ethanol-induced brain growth
retardation on GD 9.0. Moreover, the size of the first branchial arches was reduced
in the ethanol-treated group, as compared with the control group. BSE treatment
prevented the ethanol-induced decrease in the size of the first arches. (Figure
6.4A). Additionally, ethanol exposure alone significantly decreased the number of
live embryos, somite number and crown-rump length in GD 9.0 mouse embryos.
Moreover, ethanol treatment also significantly increased the incidence of neural
tube defects in mouse embryos. BSE administration significantly ameliorated
ethanol-induced growth retardation and abnormalities in GD 9.0 mouse embryos.
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Figure 6. 4. BSE administration confers in vivo protection against ethanol-induced
teratogenesis. Control and treated groups were sacrificed at GD 9.0 and the
mouse embryos were dissected. (A) Illustrated are the mouse embryos of control
and treated groups showing the ethanol-induced growth retardation and neural
tube defects and the protective effects of BSE on the ethanol-induced growth
retardation and neural tube defects. (B) Statistic analysis of the number of live
embryos somite number, crown-rump length and neural tube defects in GD 9.0
mouse embryos. Data are expressed as mean ± SEM. *p < 0.05, **p< 0.01.
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Maternal dietary administration of BSE prevented ethanol-induced
ocular abnormalities in mouse embryos.
To determine whether BSE adminstration can prevent ethanol-induced
ocular abnormalities, the control and treated mice were sacrifiered at GD 14, and
the ocular abnormalities were examined. As shown in Figure 6.5A, ethanol
exposure significantly increased the incidence of abnormalities in the right eyes.
Additionally, using the rating scale described in Figure 6.5B, I found that ethanol
administration increased the severity of ocular defects as compared with the
control group, with 24% of the right eyes in the ethanol group being mildly affected
(a rating of 2), whereas 6% of the eyes were both slightly microphthalmic and had
abnormally shaped pupils (a rating of 3), 3% of the eyes were moderately
microphthalmic (a rating of 4), and 3% were severely microphthamic (a rating of
5). Concurrent exposure of the pregnant mice to BSE and ethanol resulted in a
lower incidence and severity of ocular abnormalities compared with ethanol alone
group. The incidence of eye defects in the group treated with both ethanol andBSE
was reduced by 21% in the right eyes as compared with that in ethanol alone group.
There were no fetuses with the moderate-severe (rating of 4) or the most severe
(rating of 5) ocular defects in the group treated with both ethanol and BSE (Figure
6.5C).
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Figure 6. 5. Maternal dietary administration of BSE prevented ethanol-induced
ocular abnormalities in mouse embryos. The control and experimental mice were
sacrificed at GD 14.0 and the mouse embryos were dissected for assessment. (A)
Ocular dysmorphology was visualized under a microscope. (B) Range of ocular
defects. The eyes were rated according to the following categories: normal eye
(rating of 1) (1); slightly abnormal pupil shape (rating of 2) (2); mild microphthalmia
and slightly abnormal pupil shape (rating of 3) (3); moderate microphthalmia (rating
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of 4) (4); and severe microphthalmia (rating of 5) (5). (C) Incidence and severity of
ocular defects. Ethanol exposure resulted in significant increases in both the
incidence and severity of ocular abnormalities in both the left (*) and the right eyes
(#). Concurrent exposure to ethanol and BSE resulted in a lower incidence of
ocular defects in both the left (@) and right (+) eyes compared with ethanol alone
groups.
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D. Discussion
Apoptosis plays an important role in ethanol-induced teratogenesis. Recent
studies have shown that SFN can attenuate ethanol-induced apoptosis through
epigenetically up-regulating the anti-apoptotic genes, Bcl2 andSnail118, 133 . In this
study, I have found that maternal consumption of BSE significantly reduced
ethanol-induced down-regulations of the anti-apoptotic genes, AKT1, Bcl-2 and
NAIP, in mouse embryos through diminishing ethanol-induced hypermethylation
at the promoter regions of these anti-apoptotic genes. I have also found that BSE
administration diminished ethanol-induced apoptosis in mouse embryos, as
indicated by the reduction of cleaved caspase-3 expression. TUNEL staining also
revealed that the apoptosis in the brain and first branchial arches was significantly
reduced in ethanol and BSE co-treatment group as compared with ethanol alone
group. Maternal dietary BSE also significantly ameliorated ethanol-induced growth
retardation, neural tube defects and ocular abnormalities in mouse embryos.
SFN can modulate gene expression by inhibition of HDAC and DNMT, two
enzymes associated with histone deacetylation and DNA methylation. The
previous study in our lab has demonstrated that SFN increased acetyl-histone H3
binding to the Bcl-2 promoter, reduced ethanol-induced apoptosis in both neural
crest cells and mouse embryos18. Moreover, study has also indicated that SFN
inhibited HDAC activity in human colon235 and prostate cancer cell liness and
resulted in an increase in global and local histone acetylation status on the
promoter region of apoptosis-related genes244. In addition to modulating HDACs
and histone acetylation, SFN can also regulate DNA methylation by acting as an

126

inhibitor of DNMTs. It was reported that SFN suppressed DNA methylation in the
hTERT promoter, leading to transcriptional repression in breast cancer cells236.
Another study by Anna et al. has shown that SFN significantly decreased
enzymatic activity of DNMTs and decreased methylation on cyclin D2 promoter
regions in prostate cancer cells237. SFN is a compound produced by the conversion
of glucoraphanin in the presence of the myrosinase enzyme238. Increased amounts
of glucoraphanin can enhance SFN production in broccoli or broccoli sprouts. BSE
contains up to 50 times higher concentrations of glucoraphanin than mature
broccoli239. Consumption of BSE has been found to significantly increase
isothiocyanate levels in human plasma. Additionally, it has also been
demonstrated that SFN can cross the placenta during maternal dietary
supplementation of BSE between GD 9.0 to GD 19.0 in mice. In human subjects,
a single dose of 68 g BSE significantly inhibited HDAC activity in peripheral blood
mononuclear cells 3 hours following treatment, with the increased induction of
acetylation of histones H3 and H4125. However, the dietary BSE on DNA
methylation is not well known. In the present study, I found that maternal dietary
BSE reduced the ethanol-induced hypermethylation at the promoter regions of the
anti-apoptotic genes, including AKT1, Bcl-2, and NAIP, in mouse embryos
exposed to ethanol. In addition, SFN-rich BSE-mediated reduction of
hypermethylation at the promoter regions of these anti-apoptotic genes
significantly diminished ethanol-induced down-regulation of these genes in mouse
embryos. Maternal dietary BSE also prevented ethanol-induced apoptosis in
mouse embryos exposed to ethanol, as evidenced by the reduction of caspase-3
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activation and TUNEL staining in the group co-treated with BSE and ethanol.
These results are consistent with the study showing that SFN-enriched BSE
inhibited neuronal apoptosis through inhibition of caspase-3 activation, leading to
the neuroprotection against neurodegenerative disorders240.
Children with FASD display characteristic craniofacial anomalities, including
short palpebral fissures, hypoplastic midface, deficient philtrum and long upper
lip241, 242. Research by Dunty and Sulik has shown ethanol-induced apoptosis of
specific progenitor cells leads to craniofacial deficits associated with FASD130.
Consistent with these findings, I found that ethanol-exposed GD 9.0 mouse
embryos displayed the short first branchial arch and reduced brain size, which is
also consistent with Scott and Sulik’s study that has shown that the size of the
entire forebrain in ethanol exposed mouse embryos was significantly reduced 243.
Maternal dietary BSE significantly diminished the ethanol’s effects on the first
branchial arch and brain size in mouse embryos. In addition, BSE administration
significantly prevented the ethanol-induced reduction of the number of live
embryos, somite number, and crown-rump length and ethanol-induced neural tube
defects. These results demonstrate that maternal dietary administration of BSE
can prevent ethanol-induced growth retardation and abnormalities in GD 9.0
mouse embryos.
In the present study, ocular dysmorphology on GD 14.0 in mouse embryos
was also selected as the key morphological endpoint for analysis. The ocular
defects induced by ethanol were known to be involved in diminished global size
and pupil abnormalities243. In this study, ethanol exposure caused 36% increase
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in the ocular defects at the right eye and 16% increase in the left eye. This result
is consistent with the previous studies usingan FASD model that has shown that
the right eyes were affected at a markedly higher incidence than the left eyes231,
243, 244

. In ethanol and BSE co-treatment group, the defects of the right eye were

reduced by 21% as compared with ethanol alone group. These results
demonstrate that BSE can significantly diminish ethanol-induced ocular defects in
mouse embryos.
In summary, this study indicated that the promoter region of the anti-apoptotic
genes, includingAKT1, Bcl2 and NAIP, were hypermethylated in ethanol-exposed
mouse embryos, which can be diminished by BSE administration. Maternal dietary
BSE also diminished ethanol-induced down-regulation of the selected antiapoptotic genes and prevented ethanol-induced apoptosis in mouse embryos. In
addition, maternal dietary BSE significantly attenuated ethanol-induced growth
retardation and neural tube defects in GD 9.0 mouse embryos and ethanol-induced
ocular abnormalities in GD 14.0 mouse embryos. These findings provide insights
into the epigenetic mechanisms involved in ethanol-induced apoptosis, growth
retardation and teratogenesis in mouse embryos, suggesting that the epigenetic
modulation of anti-apoptotic genes by using SFN-rich BSE might be a promising
therapeutic strategy for the prevention of FASD.
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CHAPTER VII
DISCUSSION AND CONCLUSIONS

Restatement of goals
The overall goal of the work described in this dissertation was to elucidate the
epigenetic mechanisms by which SFN epigenetically regulates the anti-apoptotic
gene expression and prevents ethanol-induced apoptosis and teratogenesis, as
well as to develop new therapeutic approaches for the prevention of FASD. The
experiments described in Chapter III were performed to determine whether SFN
prevents the hNCCs from ethanol-induced apoptosis through altering the DNA
methylation level at the promoter regions of the anti-apoptotic genes. The study
described in Chapter IV tested the hypothesis that SFN can prevent ethanolinduced apoptosis by modulating histone acetylation at the promoter region of the
anti-apoptotic genes. The work described inn Chapter Vtested the hypothesis that
SFN can protect against ethanol-induced apoptosis by restoring EMT through
epigenetically modulating the expression of Snail1 in NCCs and that downregulation of KDM5A can prevent ethanol-induced apoptosis in NCCs and in
zebrafish embryos. The study described in Chapter VI tested the hypothesis that
maternal dietary administration of BSE can prevent ethanol-induced apoptosis and
teratogenesis through epigenetically regulating the anti-apoptotic genes. Taken
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together, these studies provide novel information on the epigenetic mechanisms
of ethanol-induced apoptosis and teratogenesis. These findings also suggest that
epigenetic modulation of anti-apoptotic genes by SFN or BSE might be a promising
strategy for the prevention of FASD.
Major findings of this dissertation
SFN protects against ethanol-induced apoptosis in hNCCs through
diminishing ethanol-induced hypermethylation at the promoters of
the anti-apoptotic genes.
Our studies described in Chapter III indicated that ethanol treatment can
inhibit the expression of the anti-apoptotic genes, including AKT1, Bcl2, BIRC5,
BIRC6, IGF1R, MCL1, NAIP and XIAP and that ethanol-induced repression of
these anti-apoptotic genes can be prevented by SFN. We have also shown that
ethanol exposure resulted in a significant increase in the DNMT activity and the
expression of DNMT3a in hNCCs. SFN can significantly diminish ethanol-induced
increases in DNMT activity and the expression of DNMT3a. We have also found
that ethanol-induced up-regulation of DNMT3a and an increase in DNMT activity
resulted in hypermethylation at the promoters of the selected anti-apoptotic genes
in hNCCs and that SFN can diminish ethanol-induced hypermethylation at the
promoters of anti-apoptotic genes by preventing ethanol-induced up-regulation of
DNMT3a and increase in DNMT activity. In addition, the knockdown of DNMT3a
or treatment with SFN significantly diminished ethanol-induced decreases in the
mRNA and protein expression of NAIP and XIAP and prevented ethanol-induced
apoptosis in hNCCs. The knockdown of DNMT3a also enhanced the effects of
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SFN on the mRNA and protein expression of NAIP and XIAP and the protective
effects of SFN on ethanol-induced apoptosis in hNCCs
SFN prevents hNCCs from ethanol-induced apoptosis by diminishing
ethanol-induced reduction of histone acetylation at the promoters of
the anti-apoptotic genes.
Our studies described in Chapter IV have indicated that ethanol exposure
can increase HDAC activity and the expression of HDAC2 in hNCCs. SFN
treatment significantly diminished ethanol-induced increase in HDAC activity and
the up-regulation of HDAC2. We have also found that ethanol-induced increase in
HDAC activity and up-regulation of HDAC2 resulted in the reduction of H3
acetylation at the promoters of AKT1, BIRC6 and XIAP in hNCCs and that SFN
diminished ethanol-induced reduction of H3 acetylation at the promoters of antiapoptotic genes by inhibiting HDAC activity and reducing ethanol-induced upregulation of HDAC2. In addition, SFN treatment or knockdown of HDAC2
significantly diminished ethanol-induced decreases in the mRNA and protein
expression of AKT1, BIRC6 and XIAP and prevented ethanol-induced apoptosis
in hNCCs. The knockdown of HDAC2 also enhanced the effects of SFN on the
mRNA and protein expression of AKT1, BIRC6 and XIAP and the protection
against ethanol-induced apoptosis in hNCCs.
SFN protects against ethanol-induced apoptosis in NCCs and
zebrafish embryos through modulating histone methylation and the
expression of Snail 1 and restoring EMT.
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Our studies presented in Chapter V indicated that ethanol exposure can
inhibit EMT through the down-regulation of Snail1 by decreasing H3K4me3
enrichment at the promoter regions of Snail1 and increase apoptosis in NCCs.
SFN treatment can diminish the ethanol-induced reduction in the H3K4me3
enrichment at the promoter regions of Snail1, restoring mRNA expression of Snail1
and EMT in NCCs exposed to ethanol. Ethanol exposure also significantly upregulated KDM5A, which can be diminished by co-treatment with SFN.
Furthermore, knockdown KDM5A by siRNA increased the expression of H3K4me3
and H3K4me3 enrichment at the Snail1 promoter. Down-regulation of KDM5A also
restored Snail1 expression and EMT process and prevented apoptosis in ethanolexposed NCCs. These results demonstrate that the disruption of EMT contributes
to ethanol-induced apoptosis in NCCs and that SFN can prevent ethanol-induced
apoptosis by restoring EMT through epigenetically regulating the expression of
EMT-related genes, suggesting that elucidation of Snail1’s role in EMT and
ethanol-induced apoptosis in NCCs may provide critical insight into the
pathogenesis of FASD.
Maternal dietary administration of SFN-rich BSE diminished ethanolinduced apoptosis and teratogenesis in mouse embryos by
epigenetically modulating anti-apoptotic genes.
The study described in Chapter VI indicated that the promoter region of the
anti-apoptotic genes, including AKT1, Bcl2 and NAIP, were hypermethylated in
ethanol-exposed mouse embryos, which can be diminished by BSE administration.
Maternal dietary BSE also diminished ethanol-induced down-regulation of the
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selected anti-apoptotic genes and prevented ethanol-induced apoptosis in mouse
embryos. In addition, maternal dietary BSE significantly attenuated ethanolinduced growth retardation and neural tube defects in GD 9.0 mouse embryos and
ethanol-induced ocular abnormalities in GD 14.0 mouse embryos. These findings
provide insight into the epigenetic mechanisms involved in ethanol-induced
apoptosis, growth retardation and teratogenesis in mouse embryos, suggesting
the epigenetic modulation of anti-apoptotic genes by using SFN-rich BSE might be
a promising therapeutic strategy for the prevention of FASD.
Significance
FASD is among the most devastating consequences of the widespread use and
abuse of alcohol. Prenatal ethanol exposure is considered to be the leading known
non-genetic cause of mental retardation in the Western world. Growing evidence
suggests a major contribution of apoptosis to ethanol-induced teratogenesis. This
discovery suggests that therapeutic strategies directed against apoptosis are
particularly valuable for the prevention of FASD. However, there is a fundamental
gap in understanding how ethanol leads to apoptosis in embryos. The continued
existence of this gap represents an important problem because, until it is filled,
understanding of ethanol-induced apoptosis that leads to teratogenesis will remain
largely incomprehensible.
Sulforaphane (SFN) is a chemical that is abundant in broccoli sprouts. It was
recently discovered that SFN can regulate gene expression through epigenetic
mechanisms, specifically by decreasing the activities of histone deacetylase and
DNA methyltransferase. This supports the potential of dietary consumption of SFN
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or SFN-rich broccoli sprouts to attenuate ethanol-induced apoptosis and confer in
vivo protection against FASD through epigenetic regulation of the expression of
anti-apoptotic genes. The objective of the work outlined in this study is to elucidate
the epigenetic mechanisms by which ethanol induces apoptosis and teratogenesis
and SFN regulates the anti-apoptotic gene expression and prevents ethanolinduced apoptosis, and to develop a safe and effective regimen to diminish the
incidence and severity of FASD using SFN or SFN-rich broccoli sprouts, a safe
“nutraceutical”.
Our studies have demonstrated that SFN protects against ethanol-induced
apoptosis in hNCCs through diminishing ethanol-induced hypermethylation at the
promoters of the anti-apoptotic genes. SFN can also prevent hNCCs from ethanolinduced apoptosis by diminishing ethanol-induced reduction of histone acetylation
at the promoters of the anti-apoptotic genes. In addition, SFN protects against
ethanol-induced apoptosis in NCCs and zebrafish embryos through modulating
histone methylation and the expression of Snail1 and restoring EMT. Moreover,
our studies have shown that maternal dietary administration of SFN-rich BSE
diminished ethanol-induced apoptosis and teratogenesis in mouse embryos by
epigenetically modulating anti-apoptotic genes. These results elucidate that
epigenetic

silencing

of

the

anti-apoptotic

genes

through

promoter

hypermethylation and histone deacetylation is involved in ethanol-induced
apoptosis and teratogenesis and that SFN can prevent ethanol-induced apoptosis
and teratogenesis by preventing the aberrant epigenetic modifications.
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These findings are significant because a better understanding of the epigenetic
mechanisms underlying ethanol-induced apoptosis is a necessary prerequisite to
the development of strategies against ethanol-induced teratogenesis. The insights
gained from this study help to define the role of SFN and broccoli sprout extract
(BSE), a diet-derived epigenetic modulator, in the prevention of FASD. These
results may establish dietary supplementation of broccoli sprout extract as a novel
strategy for the prevention of human FASD, providing high translational relevance.
Once such highly translatable strategies become available, important advances in
the intervention of FASD could be expected. Regarding its impact on scientific
advancement, the findings from this study not only advance the field of FASD
research but also contribute to a broader understanding of the epigenetic
regulation of apoptosis.
Strengths and limitations
1. Strengths
There are a number of strengths of the research work presented in this
dissertation. First, this is an innovative research work because it focuses on a
novel approach, targeting epigenetic modulation directly involved in the apoptotic
pathway, to prevent ethanol-induced apoptosis and teratogenesis. The theoretical
concept described in the application is highly innovative because this is the first
study attempting to prevent ethanol-induced apoptosis and teratogenesis
specifically through the newly recognized actions of SFN or broccoli sprout extract
as a dietary epigenetic regulator. Second, the approaches used in this research
work are also innovative. These studies combine new and exciting discoveries in
136

epigenetics with state-of-the-art approaches, including quantitative real-time PCR,
siRNA knockdown technology and ChIP-PCR approach. Third, this research
uniquely integrates in vitro cell culture and in vivo mouse and zebrafish model
systems to elucidate the mechanisms by which ethanol induces apoptosis and
teratogenesis and SFN prevents ethanol-induced apoptosis and teratogenesis.
Fourth,

these

studies

combine

epigenetic

analysis

and

morphological

characterization techniques to assess the role of SFN in modulating ethanolinduced teratogenesis. Fifth, this is the first study using human neural crest cells
(hNCCs) derived from human embryonic stem cells (hESCs) to elucidate the
mechanisms underlying FASD. The use of hNCCs in this study is more closely
mimic human responses in comparison to rodent cell lines and generates more
relevant data representing human FASD, and therefore, has high translational
potential for preventing FASD. Sixth, this research work represents the first attempt
to prevent FASD through the use of bioactive compounds derived from a vegetable.
The use of safe and effective epigenetic aberration-neutralizing dietary broccoli
sprout extract is not only innovative but also has high translational potential for
preventing FASD.
2. Limitations
There are also several limitations of the research work presented in this
dissertation. One of the limitations is the siRNA technique that has been used to
knock down the genes. It is well known that one of the major concerns for the
siRNA approach is off-target effects. For the siRNA experiments in Chapter III, IV
and V, I have used the siRNA pool, a mixture of 4 siRNAs, to target the genes of
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interest. Evidence has shown that the use of pooling of multiple siRNAs to target
gene is an effective way to reduce off-target silencing because of competition
among the siRNA in the pool. In addition, since all members of the pool silence
the same gene but have unique off-target signatures, this approach provides a
selective reduction of off-target effects245,
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. However, while the pooling of

multiple siRNAs can significantly reduce the off-target effects, it is impossible for
this approach to completely address the concern with the off-target effects of the
siRNA experiment. To further address this concern, a second siRNA pool might
be needed to validate the results from the studies using siRNA. In addition to the
siRNA technique, methylated specific PCR (MSP) that has been used to determine
the methylation at the promoter regions of the anti-apoptotic genes in Chapter III
and Chapter VI is another limitation. Although MSP is a highly effective protocol to
detect the DNA methylation status, it cannot quantify the exact methylated or
unmethylated cytosine because the products the PCR amplification was examined
on an electrophoresis gel. For this reason, follow-up studies are needed to confirm
specific cytosines that were methylated by using pyrosequencing, a protocol that
can accurately measure the degree of methylation at each CpGs with high
quantitative resolution.
Future Directions
While the findings from the study s described in this dissertation provide new
insight into the epigenetic mechanisms underlying ethanol-induced apoptosis and
teratogenesis, this work also provides a foundation for our future studies, as
outlined in this section.
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Elucidation of the molecular mechanisms underlying ethanol-induced
increase in the activity of DNMTs and HDACs and up-regulation of
DNMT3a, HDAC2 and KDM5A.
Our present study has shown that ethanol exposure can increase the activity of
DNMTs and the expression of DNMT3a in hNCCs. Ethanol treatment also resulted
in an increase in the activity of HDACs and the up-regulation of HDAC2. In addition,
exposure to ethanol significantly increased the expression of KDM5A in hNCCs.
Ethanol-induced increases in the activities of DNMTs and HDACs and the upregulation of DNMT3a and HDAC2 contribute to the hypermethylation and
reduction of the histone acetylation at the promoter regions of the anti-apoptotic
genes, the repression of anti-apoptotic genes and apoptosis in hNCCs. Upregulation of KDM5A also resulted in the reduction of H3K4me3 enrichment at the
promoters of Snail1, leading to the inhibition of EMT and apoptosis in hNCCs.
However, the mechanisms by which ethanol-induced increases in the activities of
DNMTs and HDACs, as well as the up-regulation of DNMT3a, HDAC2 and KDM5A
are not clear and could be a very interesting future direction. Elucidation of the
mechanisms underlying ethanol-induced increases in the activities of DNMTs and
HDACs and the up-regulation of DNMT3a, HDAC2 and KDM5A may identify
additional targets for the prevention of ethanol-induced apoptosis and FASD.
Determination of the synergistic pro-apoptotic effects of epigenetic
modulators, DNMTs, HDACs and KDM in ethanol-exposed hNCCs.
The results from our studies present in this dissertation have clearly shown that
an increase in the activity of DNMTs and up-regulation of DNMT3a contribute to
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ethanol-induced apoptosis in hNCCs by resulting in hypermethylation at the
promoters of the anti-apoptotic genes and repressing the expression of these
genes. We have also shown that an increase in the activity of HDACs and upregulation of HDAC2 in ethanol-exposed hNCCs resulted in the reduction of the
acetylation at the promoter regions of the anti-apoptotic genes, which also leads
to apoptosis. In addition, ethanol-induced up-regulation of KDM5A also contributes
to ethanol-induced apoptosis by modulating the histone methylation at the
promoters of Snail1. However, how these epigenetic modulators work together to
induce apoptosis in ethanol-exposed hNCCs is not clear. Determination of the
synergistic pro-apoptotic effects of DNMTs, HDACs and KDMs would be another
important future direction.
Summary and conclusions
FASD is among the most devastating consequences of the widespread use
and abuse of alcohol. Growing evidences suggest a major contribution of
apoptosis to ethanol-induced teratogenesis. This discovery suggests that
therapeutic strategies directed against apoptosis are particularly valuable for the
prevention of FASD. Sulforaphane (SFN) is a chemical that is abundant in broccoli
sprouts and can regulate gene expression through epigenetic mechanisms,
specifically by decreasing the activities of histone deacetylase and DNA
methyltransferase. The objective of this work is to elucidate the epigenetic
mechanisms by which ethanol induces apoptosis and teratogenesis and SFN
regulates the anti-apoptotic gene expression and prevents ethanol-induced
apoptosis, and to develop a safe and effective regimen to diminish the incidence
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and severity of FASD using SFN or SFN-rich broccoli sprouts. Our studies have
demonstrated that SFN protects against ethanol-induced apoptosis in hNCCs
through diminishing ethanol-induced hypermethylation at the promoters of the antiapoptotic genes. SFN can also prevent hNCCs from ethanol-induced apoptosis by
diminishing ethanol-induced reduction of histone acetylation at the promoters of
the anti-apoptotic genes. In addition, SFN protects against ethanol-induced
apoptosis in NCCs and zebrafish embryos through modulating histone methylation
and the expression of Snail1 and restoring EMT. Moreover, our studies have
shown that maternal dietary administration of SFN-rich BSE diminished ethanolinduced apoptosis and teratogenesis in mouse embryos by epigenetically
modulating anti-apoptotic genes. These results elucidate that epigenetic silencing
of the anti-apoptotic genes through promoter hypermethylation and histone
deacetylation is involved in ethanol-induced apoptosis and teratogenesis and that
SFN can prevent ethanol-induced apoptosis and teratogenesis by preventing the
aberrant epigenetic modifications. These findings provide new insight into the
epigenetic mechanisms underlying ethanol-induced apoptosis, which help to
define the role of SFN and broccoli sprout extract, a diet-derived epigenetic
modulator, in the prevention of FASD. These results may establish dietary
supplementation of broccoli sprout extract as a novel strategy for the prevention of
human FASD.
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